data_2jmy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jmy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.09 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -61.21 -25.82 67.31 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.49 -26.79 26.07 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 112.691 -2.049 . . . . 0.0 108.664 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -87.55 -16.12 35.51 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.002 178.095 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.598 ' N ' ' O ' ' A' ' 4' ' ' LEU . 6.8 mt -93.73 -30.86 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.84 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.675 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -68.97 -34.95 77.78 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.11 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -73.32 -33.01 64.92 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.258 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 76.4 t -54.9 -32.25 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.675 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 28.6 tp -51.45 -36.45 44.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.06 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 10' ' ' ALA . 4.1 tttt -77.13 -36.31 55.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.037 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.59 -6.58 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.146 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.115 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.165 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -61.55 -25.49 67.33 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.16 -26.13 25.32 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 112.695 -2.048 . . . . 0.0 108.652 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 4' ' ' LEU . 0.6 OUTLIER -87.51 -16.39 34.82 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.891 178.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.586 ' N ' ' O ' ' A' ' 4' ' ' LEU . 10.5 mt -95.36 -30.01 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.802 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.71 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -74.32 -32.36 58.14 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.965 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.91 -34.54 64.41 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.086 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.9 t -55.02 -32.03 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.71 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 5.2 tp -50.06 -36.96 31.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.234 176.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 34.7 mmtm -78.53 -36.22 45.11 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.147 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.91 -2.76 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.313 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.1 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.435 -1.195 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.4 -24.97 66.88 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -85.51 -26.98 25.91 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 112.87 -1.968 . . . . 0.0 108.712 178.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.442 ' HG2' ' HG ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.22 -15.71 35.22 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.937 178.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.561 ' N ' ' O ' ' A' ' 4' ' ' LEU . 48.5 mt -94.09 -30.92 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.871 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.637 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -68.32 -34.89 81.23 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.234 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -75.41 -31.96 60.59 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.32 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.408 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -53.07 -31.62 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.258 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.637 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -54.17 -42.69 69.91 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.264 176.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 10' ' ' ALA . 14.9 ttmt -65.83 -38.48 89.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.4 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -77.07 -8.65 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.805 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.072 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 8' ' ' ILE . 3.5 mt . . . . . 0 N--CA 1.433 -1.323 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -63.17 -23.76 67.58 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.93 -27.75 28.34 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 113.07 -1.877 . . . . 0.0 107.852 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -84.6 -12.73 53.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.205 177.08 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 4' ' ' LEU . 12.2 mt -95.0 -28.92 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.417 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.903 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -72.25 -33.65 61.65 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -74.23 -31.37 62.57 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.466 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 15' ' ' LEU . 96.0 t -56.6 -29.71 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.903 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 62.7 mt -57.04 -31.39 65.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.379 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -79.7 -38.91 32.45 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.505 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 39.4 t -72.18 -20.69 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.333 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.194 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.249 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -61.38 -25.69 67.34 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.7 OUTLIER -84.3 -28.8 26.88 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 112.721 -2.036 . . . . 0.0 108.395 178.104 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.426 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -85.87 -9.37 57.08 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.55 177.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.556 ' N ' ' O ' ' A' ' 4' ' ' LEU . 14.8 mm -94.64 -33.61 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.666 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.698 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -61.37 -39.33 97.11 Favored Glycine 0 C--N 1.314 -0.657 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.612 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -75.83 -28.41 58.26 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.177 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.21 -32.42 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.698 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 61.9 mt -54.11 -42.66 69.67 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.077 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 27.4 mttp -67.79 -34.53 76.96 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.827 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -78.51 -5.85 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.076 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.061 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.433 -1.279 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -60.41 -26.51 66.75 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 176.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.421 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -84.07 -28.2 27.74 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 112.623 -2.08 . . . . 0.0 108.649 178.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.421 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -84.36 -16.91 41.19 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.548 ' N ' ' O ' ' A' ' 4' ' ' LEU . 24.1 mt -89.63 -33.96 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.617 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.864 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -68.99 -34.9 77.58 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.598 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -69.31 -29.02 66.78 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.946 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.45 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 61.4 t -54.75 -33.94 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.864 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 2.8 mm? -51.69 -34.89 40.59 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.473 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 20.4 mttm -76.71 -38.15 54.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.991 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 2.2 t -76.12 -9.64 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.708 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.049 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.494 -1.193 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -34.11 31.65 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 111.711 -2.495 . . . . 0.0 108.159 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.26 -25.48 39.47 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 112.503 -2.135 . . . . 0.0 109.102 178.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 4' ' ' LEU . 12.2 ttpt -89.05 -12.19 41.99 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.374 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' LEU . 26.7 mt -89.25 -30.63 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.507 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.756 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -70.43 -35.22 68.58 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -68.63 -30.46 69.18 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.863 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 83.7 t -55.56 -32.2 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.756 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 81.0 mt -50.38 -36.26 31.79 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 56.0 mttt -78.83 -36.52 42.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.751 -1.568 . . . . 0.0 110.308 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.59 -4.65 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.157 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.135 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.609 ' O ' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.493 -1.23 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.54 -35.55 41.32 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 111.521 -2.581 . . . . 0.0 107.733 177.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -76.0 -26.44 56.71 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 112.531 -2.122 . . . . 0.0 108.939 177.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.609 ' N ' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.98 -10.61 47.01 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.56 178.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 4' ' ' LEU . 22.8 mt -92.94 -29.27 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.617 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.796 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -73.33 -33.59 58.7 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -72.6 -31.4 65.16 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.142 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.407 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 81.7 t -55.71 -31.48 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 177.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.796 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 59.5 mt -52.82 -35.45 57.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.358 176.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 3.9 mmpp? -76.72 -39.09 53.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.063 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -76.75 -8.43 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.896 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.136 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 8' ' ' ILE . 1.4 mp . . . . . 0 N--CA 1.434 -1.231 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -61.27 -24.89 66.72 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -85.62 -27.2 25.6 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 112.778 -2.01 . . . . 0.0 108.84 178.613 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' HG2' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -90.76 -13.4 34.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.268 178.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 4' ' ' LEU . 46.1 mt -94.21 -32.61 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.751 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.713 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -73.9 -31.19 60.37 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.149 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.68 -34.93 65.11 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.969 -0.693 . . . . 0.0 110.161 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.9 t -55.17 -31.23 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.713 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 29.2 tp -50.86 -36.86 39.9 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.123 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.2 mmtp -78.55 -36.29 44.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.154 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.46 -3.61 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.323 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.077 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 8' ' ' ILE . 1.3 mp . . . . . 0 N--CA 1.437 -1.111 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -61.3 -25.27 67.01 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.53 -26.75 26.01 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 112.776 -2.011 . . . . 0.0 108.702 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -86.72 -16.49 36.28 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.677 177.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.553 ' N ' ' O ' ' A' ' 4' ' ' LEU . 72.4 mt -95.39 -31.08 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.956 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.79 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -76.43 -29.06 58.67 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.609 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -77.31 -38.63 50.15 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.736 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.536 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 89.0 t -55.63 -31.36 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.79 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 2.6 tm? -51.77 -33.61 35.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.348 -1.297 . . . . 0.0 108.739 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -83.75 -35.72 24.17 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.343 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.536 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 41.1 t -81.37 3.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.276 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.108 -179.518 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.291 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -60.73 -26.47 67.22 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.407 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -84.46 -27.14 27.71 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 112.634 -2.076 . . . . 0.0 108.686 178.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HD3' ' HG ' ' A' ' 4' ' ' LEU . 1.4 pttt -85.69 -17.84 34.84 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.554 ' N ' ' O ' ' A' ' 4' ' ' LEU . 8.1 mt -92.38 -29.57 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.702 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.674 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -72.77 -33.76 60.03 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.947 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -71.61 -31.47 66.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.958 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 15' ' ' LEU . 79.0 t -55.12 -31.88 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.674 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 31.9 tp -52.59 -35.27 53.89 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.623 -1.172 . . . . 0.0 108.351 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -75.93 -40.06 54.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.053 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.04 -9.04 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.882 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 11' ' ' VAL . 2.0 tp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.212 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 7' ' ' LYS . 3.4 mt . . . . . 0 CA--C 1.493 -1.218 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.87 -34.7 60.17 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 111.614 -2.539 . . . . 0.0 107.889 177.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.48 -25.27 50.28 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.753 -2.022 . . . . 0.0 108.38 177.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.1 -8.24 55.77 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.212 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' A' ' 4' ' ' LEU . 5.9 mm -93.29 -30.55 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.316 0.579 . . . . 0.0 110.159 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.807 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -73.13 -32.21 60.72 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.041 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.549 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.09 -33.76 65.8 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.116 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.459 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 96.5 t -55.79 -30.75 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.807 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 1.0 OUTLIER -53.85 -33.27 55.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.653 176.523 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 6.9 mtmm -79.33 -39.12 33.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.505 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 20.3 t -69.42 -18.72 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.387 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.344 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.437 -1.075 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -63.14 -22.22 66.72 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -86.81 -27.83 23.3 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 113.111 -1.859 . . . . 0.0 108.051 177.637 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.41 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -86.05 -7.88 58.31 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.436 177.471 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' LEU . 65.7 mt -95.39 -33.34 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.041 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.753 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -64.89 -36.45 93.11 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.163 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -75.21 -34.62 61.51 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.231 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.488 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 84.9 t -55.84 -30.61 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.753 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -52.8 -34.75 54.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.383 176.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 10' ' ' ALA . 5.4 tptp -78.8 -39.53 35.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.05 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 2.6 t -74.49 -9.62 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.783 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 tp . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.235 -179.611 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.433 -1.277 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -62.06 -24.81 67.31 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.407 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 1.0 OUTLIER -84.71 -28.06 26.58 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 112.731 -2.031 . . . . 0.0 108.07 177.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -84.75 -12.25 54.11 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.386 177.178 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.566 ' N ' ' O ' ' A' ' 4' ' ' LEU . 43.0 mt -95.81 -32.76 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.227 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.797 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -70.28 -31.76 68.79 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.471 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -77.16 -37.94 52.77 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.633 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.405 HG13 HG12 ' A' ' 14' ' ' VAL . 91.4 t -55.84 -30.2 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.797 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 14.3 tp -52.08 -37.03 52.62 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.506 -1.224 . . . . 0.0 107.887 176.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 4.1 mtmm -81.22 -31.91 33.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.405 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.405 HG12 HG13 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -79.01 7.07 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.715 -178.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.9 tp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.387 -179.142 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.137 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -61.57 -25.33 67.25 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.404 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -84.81 -27.72 26.61 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 112.86 -1.973 . . . . 0.0 108.477 178.153 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.404 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -86.21 -14.14 44.81 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.739 177.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' LEU . 40.4 mt -95.73 -31.21 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.739 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.762 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -69.5 -33.2 71.97 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.46 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -76.27 -38.35 56.35 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.477 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -55.27 -31.06 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.762 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 48.1 tp -49.84 -37.01 28.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.111 176.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.0 mmpt? -80.89 -34.83 33.28 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.632 -1.622 . . . . 0.0 110.159 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.65 0.53 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.376 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.12 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.213 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -61.28 -25.26 66.98 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -83.87 -28.65 27.81 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 112.885 -1.962 . . . . 0.0 108.335 178.203 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.415 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -81.83 -17.09 48.65 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.291 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' LEU . 1.7 mp -99.48 -29.41 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.372 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.825 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -72.96 -33.14 60.03 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.95 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -77.05 -36.82 55.69 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.795 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.561 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 94.5 t -56.54 -30.29 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.825 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 66.8 tp -52.08 -34.63 44.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.448 176.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 23.9 mtpp -81.73 -38.13 26.22 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.226 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.561 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 7.6 t -75.99 -7.69 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.965 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' VAL . 1.4 tp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.12 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.437 -1.092 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -61.01 -25.94 67.25 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.6 OUTLIER -85.41 -26.84 26.16 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 112.721 -2.036 . . . . 0.0 108.669 178.346 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.05 -14.42 39.01 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.096 178.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 4' ' ' LEU . 44.8 mt -96.53 -30.41 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.811 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.844 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -74.88 -31.21 58.35 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.16 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -77.06 -34.41 57.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.388 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.409 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 86.5 t -55.62 -31.36 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.844 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 68.5 mt -53.27 -35.54 60.18 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.305 176.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 10' ' ' ALA . 65.3 tttt -76.14 -40.14 53.42 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.046 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.409 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -76.04 -9.08 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.817 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.098 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 8' ' ' ILE . 1.5 mp . . . . . 0 N--CA 1.436 -1.165 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -61.01 -25.69 67.08 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.444 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -83.85 -28.64 27.86 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 112.75 -2.023 . . . . 0.0 108.695 178.453 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -86.38 -13.73 45.52 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.736 177.878 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 4' ' ' LEU . 11.2 mt -94.48 -31.35 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.874 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.837 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -64.64 -37.28 94.18 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.297 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -75.67 -32.76 60.29 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.243 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.431 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 68.0 t -56.37 -31.16 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.837 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 27.6 mt -52.86 -35.24 57.35 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.403 176.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 9.1 mttp -77.5 -40.16 43.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.14 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.431 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 1.9 t -75.81 -9.65 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.863 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.131 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.436 -1.164 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -61.17 -25.66 67.17 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 2.3 ptmt -85.43 -26.96 26.07 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 112.67 -2.059 . . . . 0.0 108.639 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.406 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -86.88 -16.39 36.16 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.928 177.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.587 ' N ' ' O ' ' A' ' 4' ' ' LEU . 24.9 mt -94.3 -31.05 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.716 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.71 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -72.06 -33.25 62.5 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.95 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.22 -33.46 65.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.102 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.408 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 66.0 t -55.43 -30.23 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.71 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 46.7 tp -53.61 -35.2 60.64 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.404 176.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 7.8 mmtt -77.22 -39.82 47.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.095 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 1.1 t -75.86 -9.3 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.795 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 11' ' ' VAL . 2.2 tp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.132 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.652 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 121.518 0.675 . . . . 0.0 111.505 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.748 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.79 -107.32 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 118.363 2.727 . . . . 0.0 118.363 -176.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -91.44 -10.75 39.82 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 121.937 0.875 . . . . 0.0 112.601 -175.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.627 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -98.38 -25.31 14.86 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.483 177.268 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.652 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 23.4 t80 -61.21 -25.82 67.31 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -85.49 -26.79 26.07 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 112.691 -2.049 . . . . 0.0 108.664 178.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -87.55 -16.12 35.51 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.002 178.095 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.598 ' N ' ' O ' ' A' ' 4' ' ' LEU . 6.8 mt -93.73 -30.86 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.84 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.675 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -68.97 -34.95 77.78 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.11 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -73.32 -33.01 64.92 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.258 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 76.4 t -54.9 -32.25 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.675 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 28.6 tp -51.45 -36.45 44.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.06 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 10' ' ' ALA . 4.1 tttt -77.13 -36.31 55.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.037 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.59 -6.58 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.146 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.115 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.634 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 11.4 pttp . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.461 0.648 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.746 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.09 -107.14 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -176.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 44.9 mtmt -91.5 -10.39 40.97 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 121.956 0.884 . . . . 0.0 112.745 -175.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.614 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -98.31 -25.77 14.73 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.426 177.266 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.634 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 28.4 t80 -61.55 -25.49 67.33 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 176.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -86.16 -26.13 25.32 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 112.695 -2.048 . . . . 0.0 108.652 178.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 4' ' ' LEU . 0.6 OUTLIER -87.51 -16.39 34.82 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.891 178.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.586 ' N ' ' O ' ' A' ' 4' ' ' LEU . 10.5 mt -95.36 -30.01 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.802 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.71 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -74.32 -32.36 58.14 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.965 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.91 -34.54 64.41 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.086 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.9 t -55.02 -32.03 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.71 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 5.2 tp -50.06 -36.96 31.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.234 176.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 34.7 mmtm -78.53 -36.22 45.11 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.147 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.91 -2.76 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.313 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.1 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.635 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.383 0.611 . . . . 0.0 111.587 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.759 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.03 -107.0 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 118.437 2.754 . . . . 0.0 118.437 -176.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.53 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 16.0 tttt -91.8 -9.69 42.62 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.952 0.882 . . . . 0.0 112.804 -175.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.644 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.9 OUTLIER -98.18 -26.99 14.37 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.197 177.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.635 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 32.0 t80 -61.4 -24.97 66.88 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 176.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -85.51 -26.98 25.91 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 112.87 -1.968 . . . . 0.0 108.712 178.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.442 ' HG2' ' HG ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.22 -15.71 35.22 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.937 178.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.561 ' N ' ' O ' ' A' ' 4' ' ' LEU . 48.5 mt -94.09 -30.92 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.871 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.637 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -68.32 -34.89 81.23 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.234 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -75.41 -31.96 60.59 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.32 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.408 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -53.07 -31.62 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.258 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.637 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -54.17 -42.69 69.91 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.264 176.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 10' ' ' ALA . 14.9 ttmt -65.83 -38.48 89.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.4 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -77.07 -8.65 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.805 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.072 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.651 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.276 0.56 . . . . 0.0 111.551 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.764 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.9 -107.97 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 118.364 2.727 . . . . 0.0 118.364 -176.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 13.3 mmtt -90.96 -11.3 39.4 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 122.07 0.938 . . . . 0.0 112.36 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.707 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 3.5 mt -98.27 -25.61 14.8 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-N 114.198 -1.364 . . . . 0.0 108.797 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.651 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 44.1 t80 -63.17 -23.76 67.58 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -83.93 -27.75 28.34 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 113.07 -1.877 . . . . 0.0 107.852 177.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -84.6 -12.73 53.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.205 177.08 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 4' ' ' LEU . 12.2 mt -95.0 -28.92 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.417 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.903 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -72.25 -33.65 61.65 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -74.23 -31.37 62.57 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.466 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 15' ' ' LEU . 96.0 t -56.6 -29.71 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.903 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 62.7 mt -57.04 -31.39 65.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.379 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -79.7 -38.91 32.45 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.505 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 39.4 t -72.18 -20.69 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.333 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.194 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.659 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 4.1 pttp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.257 0.551 . . . . 0.0 111.925 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.755 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -77.12 -107.37 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 118.48 2.77 . . . . 0.0 118.48 -176.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -91.01 -10.83 40.8 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 121.931 0.872 . . . . 0.0 112.621 -175.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.646 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -98.49 -25.07 14.89 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.585 177.196 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.659 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 37.1 t80 -61.38 -25.69 67.34 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.541 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -84.3 -28.8 26.88 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 112.721 -2.036 . . . . 0.0 108.395 178.104 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.426 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -85.87 -9.37 57.08 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.55 177.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.556 ' N ' ' O ' ' A' ' 4' ' ' LEU . 14.8 mm -94.64 -33.61 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.666 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.698 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -61.37 -39.33 97.11 Favored Glycine 0 C--N 1.314 -0.657 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.612 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -75.83 -28.41 58.26 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.177 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.21 -32.42 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.698 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 61.9 mt -54.11 -42.66 69.67 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.077 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 27.4 mttp -67.79 -34.53 76.96 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.827 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -78.51 -5.85 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.076 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.061 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.518 ' CB ' ' HB2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.736 0.303 . . . . 0.0 111.601 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.73 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -75.04 -106.91 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 119.408 3.114 . . . . 0.0 119.408 -175.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 7.5 mtpp -90.19 -10.79 43.11 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.995 0.902 . . . . 0.0 112.866 -174.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.658 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 1.0 OUTLIER -98.35 -25.42 14.83 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.464 177.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.518 ' HB2' ' CB ' ' A' ' 1' ' ' LYS . 19.3 t80 -60.41 -26.51 66.75 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.542 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -84.07 -28.2 27.74 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 112.623 -2.08 . . . . 0.0 108.649 178.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.421 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -84.36 -16.91 41.19 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.548 ' N ' ' O ' ' A' ' 4' ' ' LEU . 24.1 mt -89.63 -33.96 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.617 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.864 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -68.99 -34.9 77.58 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.598 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -69.31 -29.02 66.78 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.946 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.45 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 61.4 t -54.75 -33.94 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.864 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 2.8 mm? -51.69 -34.89 40.59 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.473 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 20.4 mttm -76.71 -38.15 54.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.991 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 2.2 t -76.12 -9.64 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.708 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.049 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.585 ' O ' ' HB2' ' A' ' 5' ' ' PHE . 3.2 ptpp? . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.268 0.556 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.757 ' HE3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -88.33 -95.17 0.1 Allowed 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -178.14 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.757 ' N ' ' HE3' ' A' ' 2' ' ' TRP . 0.1 OUTLIER -80.15 4.38 17.58 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 121.643 0.735 . . . . 0.0 111.883 -179.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.748 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -93.39 -45.9 7.59 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 177.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.585 ' HB2' ' O ' ' A' ' 1' ' ' LYS . 0.2 OUTLIER -51.29 -34.11 31.65 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 111.711 -2.495 . . . . 0.0 108.159 177.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER -80.26 -25.48 39.47 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 112.503 -2.135 . . . . 0.0 109.102 178.06 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 4' ' ' LEU . 12.2 ttpt -89.05 -12.19 41.99 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.374 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' LEU . 26.7 mt -89.25 -30.63 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.507 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.756 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -70.43 -35.22 68.58 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -68.63 -30.46 69.18 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.863 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 83.7 t -55.56 -32.2 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.756 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 81.0 mt -50.38 -36.26 31.79 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 56.0 mttt -78.83 -36.52 42.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.751 -1.568 . . . . 0.0 110.308 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.59 -4.65 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.157 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.135 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 121.429 0.633 . . . . 0.0 111.478 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.753 ' HE3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -88.78 -95.85 0.1 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -178.032 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.753 ' N ' ' HE3' ' A' ' 2' ' ' TRP . 3.5 mptp? -80.05 4.79 16.01 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-O 121.584 0.707 . . . . 0.0 111.894 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.746 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -93.07 -48.26 6.58 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.038 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.582 ' HB2' ' O ' ' A' ' 1' ' ' LYS . 0.3 OUTLIER -51.54 -35.55 41.32 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 111.521 -2.581 . . . . 0.0 107.733 177.374 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.476 ' HG2' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -76.0 -26.44 56.71 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 112.531 -2.122 . . . . 0.0 108.939 177.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.609 ' N ' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.98 -10.61 47.01 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.56 178.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 4' ' ' LEU . 22.8 mt -92.94 -29.27 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.617 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.796 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -73.33 -33.59 58.7 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -72.6 -31.4 65.16 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.142 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.407 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 81.7 t -55.71 -31.48 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 177.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.796 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 59.5 mt -52.82 -35.45 57.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.358 176.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 3.9 mmpp? -76.72 -39.09 53.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.063 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -76.75 -8.43 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.896 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.136 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.656 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.033 0.444 . . . . 0.0 111.526 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.751 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -78.16 -108.26 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 118.515 2.783 . . . . 0.0 118.515 -176.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 10.1 ttpp -91.9 -10.82 38.19 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 122.077 0.941 . . . . 0.0 112.676 -175.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.664 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 1.4 mp -97.99 -26.65 14.56 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.354 -1.293 . . . . 0.0 108.215 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.656 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 32.9 t80 -61.27 -24.89 66.72 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 176.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -85.62 -27.2 25.6 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 112.778 -2.01 . . . . 0.0 108.84 178.613 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' HG2' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -90.76 -13.4 34.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.268 178.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 4' ' ' LEU . 46.1 mt -94.21 -32.61 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.751 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.713 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -73.9 -31.19 60.37 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.149 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.68 -34.93 65.11 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.969 -0.693 . . . . 0.0 110.161 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.9 t -55.17 -31.23 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.713 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 29.2 tp -50.86 -36.86 39.9 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.123 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.2 mmtp -78.55 -36.29 44.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.154 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.46 -3.61 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.323 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.077 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.643 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.125 0.488 . . . . 0.0 112.196 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.749 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.39 -107.18 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 118.531 2.789 . . . . 0.0 118.531 -176.451 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 4.6 ttpt -91.32 -10.67 40.45 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.921 0.867 . . . . 0.0 112.71 -175.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.619 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 1.3 mp -98.16 -26.37 14.59 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.441 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.643 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 34.7 t80 -61.3 -25.27 67.01 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -85.53 -26.75 26.01 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 112.776 -2.011 . . . . 0.0 108.702 178.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -86.72 -16.49 36.28 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.677 177.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.553 ' N ' ' O ' ' A' ' 4' ' ' LEU . 72.4 mt -95.39 -31.08 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.956 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.79 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -76.43 -29.06 58.67 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.609 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -77.31 -38.63 50.15 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.736 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.536 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 89.0 t -55.63 -31.36 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.79 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 2.6 tm? -51.77 -33.61 35.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.348 -1.297 . . . . 0.0 108.739 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -83.75 -35.72 24.17 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.343 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.536 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 41.1 t -81.37 3.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.276 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.108 -179.518 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.512 ' CB ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.881 0.372 . . . . 0.0 111.732 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.75 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -74.57 -106.6 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 119.165 3.024 . . . . 0.0 119.165 -176.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 9.8 mttt -91.27 -8.89 47.03 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 121.841 0.829 . . . . 0.0 112.844 -175.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.645 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -98.35 -26.17 14.58 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.172 176.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.512 ' HB2' ' CB ' ' A' ' 1' ' ' LYS . 21.2 t80 -60.73 -26.47 67.22 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.54 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -84.46 -27.14 27.71 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 112.634 -2.076 . . . . 0.0 108.686 178.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HD3' ' HG ' ' A' ' 4' ' ' LEU . 1.4 pttt -85.69 -17.84 34.84 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.554 ' N ' ' O ' ' A' ' 4' ' ' LEU . 8.1 mt -92.38 -29.57 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.702 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.674 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -72.77 -33.76 60.03 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.947 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -71.61 -31.47 66.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.958 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 15' ' ' LEU . 79.0 t -55.12 -31.88 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.674 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 31.9 tp -52.59 -35.27 53.89 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.623 -1.172 . . . . 0.0 108.351 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -75.93 -40.06 54.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.053 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.04 -9.04 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.882 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 11' ' ' VAL . 2.0 tp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.212 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.224 0.535 . . . . 0.0 111.662 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.76 ' HE3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -89.22 -94.87 0.1 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -178.169 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.76 ' N ' ' HE3' ' A' ' 2' ' ' TRP . 0.1 OUTLIER -79.9 5.04 14.85 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 121.726 0.774 . . . . 0.0 111.867 -179.444 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.736 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 3.4 mt -94.65 -47.39 6.53 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 177.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.607 ' HB2' ' O ' ' A' ' 1' ' ' LYS . 0.3 OUTLIER -53.87 -34.7 60.17 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 111.614 -2.539 . . . . 0.0 107.889 177.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -77.48 -25.27 50.28 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.753 -2.022 . . . . 0.0 108.38 177.378 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.1 -8.24 55.77 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.212 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' A' ' 4' ' ' LEU . 5.9 mm -93.29 -30.55 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.316 0.579 . . . . 0.0 110.159 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.807 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -73.13 -32.21 60.72 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.041 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.549 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.09 -33.76 65.8 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.116 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.459 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 96.5 t -55.79 -30.75 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.807 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 1.0 OUTLIER -53.85 -33.27 55.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.653 176.523 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 6.9 mtmm -79.33 -39.12 33.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.505 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 20.3 t -69.42 -18.72 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.387 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.344 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.663 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 2.4 pttp . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.46 0.647 . . . . 0.0 111.623 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.747 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.67 -105.95 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 119.052 2.982 . . . . 0.0 119.052 -176.249 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.507 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 8.1 mmtp -89.64 -13.06 37.87 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.856 0.836 . . . . 0.0 112.736 -175.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -98.16 -27.09 14.34 Favored 'General case' 0 C--N 1.284 -2.283 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.062 177.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.663 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 76.7 t80 -63.14 -22.22 66.72 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -86.81 -27.83 23.3 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 113.111 -1.859 . . . . 0.0 108.051 177.637 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.41 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -86.05 -7.88 58.31 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.436 177.471 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' LEU . 65.7 mt -95.39 -33.34 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.041 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.753 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -64.89 -36.45 93.11 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.163 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -75.21 -34.62 61.51 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.231 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.488 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 84.9 t -55.84 -30.61 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.753 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -52.8 -34.75 54.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.383 176.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 10' ' ' ALA . 5.4 tptp -78.8 -39.53 35.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.05 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 2.6 t -74.49 -9.62 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.783 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 tp . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.235 -179.611 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.562 ' CB ' ' HB2' ' A' ' 5' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 120.846 0.355 . . . . 0.0 111.838 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.713 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -74.22 -107.41 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 119.432 3.123 . . . . 0.0 119.432 -175.718 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.552 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 74.9 mttt -91.01 -9.7 44.97 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 122.025 0.917 . . . . 0.0 112.739 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.663 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.1 OUTLIER -98.95 -24.75 14.82 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.399 176.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.562 ' HB2' ' CB ' ' A' ' 1' ' ' LYS . 41.9 t80 -62.06 -24.81 67.31 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.552 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 1.0 OUTLIER -84.71 -28.06 26.58 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 112.731 -2.031 . . . . 0.0 108.07 177.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -84.75 -12.25 54.11 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.386 177.178 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.566 ' N ' ' O ' ' A' ' 4' ' ' LEU . 43.0 mt -95.81 -32.76 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.227 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.797 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -70.28 -31.76 68.79 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.471 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -77.16 -37.94 52.77 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.633 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.405 HG13 HG12 ' A' ' 14' ' ' VAL . 91.4 t -55.84 -30.2 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.797 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 14.3 tp -52.08 -37.03 52.62 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.506 -1.224 . . . . 0.0 107.887 176.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 4.1 mtmm -81.22 -31.91 33.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.405 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.405 HG12 HG13 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -79.01 7.07 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.715 -178.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.9 tp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.387 -179.142 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.662 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.437 0.637 . . . . 0.0 111.467 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.748 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.5 -107.09 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 118.479 2.77 . . . . 0.0 118.479 -176.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.539 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 14.8 mtpp -90.95 -11.11 40.01 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 122.035 0.922 . . . . 0.0 112.625 -175.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.631 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -98.28 -25.36 14.88 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.679 177.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.662 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 33.2 t80 -61.57 -25.33 67.25 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.539 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -84.81 -27.72 26.61 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 112.86 -1.973 . . . . 0.0 108.477 178.153 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.404 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -86.21 -14.14 44.81 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.739 177.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' LEU . 40.4 mt -95.73 -31.21 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.739 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.762 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -69.5 -33.2 71.97 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.46 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -76.27 -38.35 56.35 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.477 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -55.27 -31.06 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.762 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 48.1 tp -49.84 -37.01 28.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.111 176.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.0 mmpt? -80.89 -34.83 33.28 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.632 -1.622 . . . . 0.0 110.159 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.65 0.53 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.376 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.12 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.652 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.458 0.647 . . . . 0.0 111.571 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.761 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -77.99 -107.31 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 118.553 2.797 . . . . 0.0 118.553 -176.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -91.17 -11.2 39.1 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.054 0.93 . . . . 0.0 112.523 -175.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.64 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -98.34 -25.67 14.75 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.606 177.252 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.652 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 27.3 t80 -61.28 -25.26 66.98 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 176.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.542 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -83.87 -28.65 27.81 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 112.885 -1.962 . . . . 0.0 108.335 178.203 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -81.83 -17.09 48.65 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.291 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' LEU . 1.7 mp -99.48 -29.41 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.372 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.825 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -72.96 -33.14 60.03 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.95 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -77.05 -36.82 55.69 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.795 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.561 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 94.5 t -56.54 -30.29 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.825 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 66.8 tp -52.08 -34.63 44.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.448 176.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 23.9 mtpp -81.73 -38.13 26.22 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.226 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.561 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 7.6 t -75.99 -7.69 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.965 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' VAL . 1.4 tp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.12 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.637 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 18.6 pttm . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.523 0.677 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.753 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.03 -107.04 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 118.375 2.731 . . . . 0.0 118.375 -176.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.53 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 0.2 OUTLIER -91.54 -10.27 41.25 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.846 0.832 . . . . 0.0 112.593 -175.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.618 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.1 OUTLIER -98.37 -25.72 14.73 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.442 177.175 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.637 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 25.6 t80 -61.01 -25.94 67.25 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -85.41 -26.84 26.16 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 112.721 -2.036 . . . . 0.0 108.669 178.346 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.05 -14.42 39.01 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.096 178.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 4' ' ' LEU . 44.8 mt -96.53 -30.41 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.811 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.844 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -74.88 -31.21 58.35 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.16 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -77.06 -34.41 57.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.388 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.409 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 86.5 t -55.62 -31.36 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.844 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 68.5 mt -53.27 -35.54 60.18 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.305 176.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 10' ' ' ALA . 65.3 tttt -76.14 -40.14 53.42 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.046 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.409 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -76.04 -9.08 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.817 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.098 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.661 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.142 0.496 . . . . 0.0 111.705 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.766 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -77.86 -107.95 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 118.32 2.711 . . . . 0.0 118.32 -176.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.551 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -91.96 -10.65 38.62 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.094 0.95 . . . . 0.0 112.554 -175.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.678 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 1.5 mp -98.2 -25.96 14.71 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.272 177.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.661 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 28.3 t80 -61.01 -25.69 67.08 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 176.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.551 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -83.85 -28.64 27.86 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 112.75 -2.023 . . . . 0.0 108.695 178.453 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -86.38 -13.73 45.52 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.736 177.878 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 4' ' ' LEU . 11.2 mt -94.48 -31.35 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.874 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.837 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -64.64 -37.28 94.18 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.297 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -75.67 -32.76 60.29 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.243 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.431 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 68.0 t -56.37 -31.16 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.837 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 27.6 mt -52.86 -35.24 57.35 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.403 176.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 9.1 mttp -77.5 -40.16 43.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.14 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.431 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 1.9 t -75.81 -9.65 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.863 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.131 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.637 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 6.9 pttt . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.46 0.648 . . . . 0.0 111.481 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.759 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.28 -107.0 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 -176.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.525 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 0.2 OUTLIER -91.39 -10.06 42.46 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.986 0.898 . . . . 0.0 112.663 -175.736 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.62 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.1 OUTLIER -98.36 -25.86 14.68 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.452 177.15 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.637 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 28.3 t80 -61.17 -25.66 67.17 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 2.3 ptmt -85.43 -26.96 26.07 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 112.67 -2.059 . . . . 0.0 108.639 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.406 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -86.88 -16.39 36.16 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.928 177.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.587 ' N ' ' O ' ' A' ' 4' ' ' LEU . 24.9 mt -94.3 -31.05 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.716 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.71 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -72.06 -33.25 62.5 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.95 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.22 -33.46 65.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.102 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.408 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 66.0 t -55.43 -30.23 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.71 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 46.7 tp -53.61 -35.2 60.64 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.404 176.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 7.8 mmtt -77.22 -39.82 47.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.095 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 1.1 t -75.86 -9.3 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.795 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 11' ' ' VAL . 2.2 tp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.132 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.09 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -61.21 -25.82 67.31 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -85.49 -26.79 26.07 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 112.691 -2.049 . . . . 0.0 108.664 178.404 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.696 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -87.55 -16.12 35.51 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.002 178.095 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.598 ' N ' ' O ' ' A' ' 4' ' ' LEU . 6.8 mt -93.73 -30.86 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.84 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.686 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -68.97 -34.95 77.78 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.11 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -73.32 -33.01 64.92 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.258 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 7' ' ' LYS . 76.4 t -54.9 -32.25 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.686 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 28.6 tp -51.45 -36.45 44.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.06 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 10' ' ' ALA . 4.1 tttt -77.13 -36.31 55.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.037 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.59 -6.58 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.146 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.115 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.165 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -61.55 -25.49 67.33 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.16 -26.13 25.32 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 112.695 -2.048 . . . . 0.0 108.652 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.746 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -87.51 -16.39 34.82 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.891 178.093 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.586 ' N ' ' O ' ' A' ' 4' ' ' LEU . 10.5 mt -95.36 -30.01 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.802 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.72 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -74.32 -32.36 58.14 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.965 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.91 -34.54 64.41 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.086 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 7' ' ' LYS . 63.9 t -55.02 -32.03 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.72 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 5.2 tp -50.06 -36.96 31.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.234 176.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 34.7 mmtm -78.53 -36.22 45.11 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.147 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -78.91 -2.76 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.313 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.645 HD13 HG12 ' A' ' 11' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.1 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.435 -1.195 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.4 -24.97 66.88 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -85.51 -26.98 25.91 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 112.87 -1.968 . . . . 0.0 108.712 178.452 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HG2' ' HG ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.22 -15.71 35.22 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.937 178.108 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.561 ' N ' ' O ' ' A' ' 4' ' ' LEU . 48.5 mt -94.09 -30.92 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.871 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.652 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -68.32 -34.89 81.23 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.234 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -75.41 -31.96 60.59 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.32 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -31.62 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.652 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -54.17 -42.69 69.91 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.264 176.427 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 10' ' ' ALA . 14.9 ttmt -65.83 -38.48 89.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.4 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.07 -8.65 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.805 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.072 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.811 HD23 ' HB3' ' A' ' 7' ' ' LYS . 3.5 mt . . . . . 0 N--CA 1.433 -1.323 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -63.17 -23.76 67.58 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.93 -27.75 28.34 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 113.07 -1.877 . . . . 0.0 107.852 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.811 ' HB3' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -84.6 -12.73 53.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.205 177.08 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 4' ' ' LEU . 12.2 mt -95.0 -28.92 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.417 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.895 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -72.25 -33.65 61.65 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -74.23 -31.37 62.57 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.466 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 7' ' ' LYS . 96.0 t -56.6 -29.71 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.895 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 62.7 mt -57.04 -31.39 65.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.379 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -79.7 -38.91 32.45 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.505 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.18 -20.69 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.333 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.194 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.249 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -61.38 -25.69 67.34 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.7 OUTLIER -84.3 -28.8 26.88 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 112.721 -2.036 . . . . 0.0 108.395 178.104 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.431 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -85.87 -9.37 57.08 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.55 177.552 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.556 ' N ' ' O ' ' A' ' 4' ' ' LEU . 14.8 mm -94.64 -33.61 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.666 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.687 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -61.37 -39.33 97.11 Favored Glycine 0 C--N 1.314 -0.657 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.599 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -75.83 -28.41 58.26 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.177 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.21 -32.42 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.687 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 61.9 mt -54.11 -42.66 69.67 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.077 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 27.4 mttp -67.79 -34.53 76.96 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.827 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -78.51 -5.85 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.076 -179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.061 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.784 HD23 ' HB3' ' A' ' 7' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.433 -1.279 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -60.41 -26.51 66.75 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 176.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -84.07 -28.2 27.74 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 112.623 -2.08 . . . . 0.0 108.649 178.689 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.784 ' HB3' HD23 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -84.36 -16.91 41.19 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.648 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.548 ' N ' ' O ' ' A' ' 4' ' ' LEU . 24.1 mt -89.63 -33.96 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.617 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.86 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -68.99 -34.9 77.58 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.586 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -69.31 -29.02 66.78 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.946 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 7' ' ' LYS . 61.4 t -54.75 -33.94 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.86 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 2.8 mm? -51.69 -34.89 40.59 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.473 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.586 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 20.4 mttm -76.71 -38.15 54.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.991 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 2.2 t -76.12 -9.64 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.708 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.049 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.494 -1.193 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -34.11 31.65 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 111.711 -2.495 . . . . 0.0 108.159 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.26 -25.48 39.47 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 112.503 -2.135 . . . . 0.0 109.102 178.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 4' ' ' LEU . 12.2 ttpt -89.05 -12.19 41.99 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.374 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' LEU . 26.7 mt -89.25 -30.63 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.507 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.742 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -70.43 -35.22 68.58 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -68.63 -30.46 69.18 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.863 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 7' ' ' LYS . 83.7 t -55.56 -32.2 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.742 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 81.0 mt -50.38 -36.26 31.79 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 56.0 mttt -78.83 -36.52 42.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.751 -1.568 . . . . 0.0 110.308 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -78.59 -4.65 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.157 -179.616 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.135 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.609 ' O ' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.493 -1.23 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.54 -35.55 41.32 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 111.521 -2.581 . . . . 0.0 107.733 177.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -76.0 -26.44 56.71 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 112.531 -2.122 . . . . 0.0 108.939 177.738 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.697 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -88.98 -10.61 47.01 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.56 178.988 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 4' ' ' LEU . 22.8 mt -92.94 -29.27 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.617 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.784 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -73.33 -33.59 58.7 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -72.6 -31.4 65.16 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.142 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 7' ' ' LYS . 81.7 t -55.71 -31.48 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 177.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.784 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 59.5 mt -52.82 -35.45 57.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.358 176.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 3.9 mmpp? -76.72 -39.09 53.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.063 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.406 ' O ' ' CG1' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -76.75 -8.43 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.896 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.136 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 8' ' ' ILE . 1.4 mp . . . . . 0 N--CA 1.434 -1.231 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -61.27 -24.89 66.72 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -85.62 -27.2 25.6 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 112.778 -2.01 . . . . 0.0 108.84 178.613 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.716 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -90.76 -13.4 34.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.268 178.256 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 4' ' ' LEU . 46.1 mt -94.21 -32.61 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.751 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.725 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -73.9 -31.19 60.37 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.149 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.68 -34.93 65.11 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.969 -0.693 . . . . 0.0 110.161 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 7' ' ' LYS . 72.9 t -55.17 -31.23 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.725 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 29.2 tp -50.86 -36.86 39.9 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.123 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.2 mmtp -78.55 -36.29 44.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.154 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -78.46 -3.61 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.323 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.077 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 8' ' ' ILE . 1.3 mp . . . . . 0 N--CA 1.437 -1.111 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -61.3 -25.27 67.01 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.53 -26.75 26.01 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 112.776 -2.011 . . . . 0.0 108.702 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.588 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -86.72 -16.49 36.28 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.677 177.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.553 ' N ' ' O ' ' A' ' 4' ' ' LEU . 72.4 mt -95.39 -31.08 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.956 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.799 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -76.43 -29.06 58.67 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.609 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -77.31 -38.63 50.15 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.736 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 7' ' ' LYS . 89.0 t -55.63 -31.36 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.799 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 2.6 tm? -51.77 -33.61 35.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.348 -1.297 . . . . 0.0 108.739 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -83.75 -35.72 24.17 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.343 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.574 ' O ' HG12 ' A' ' 14' ' ' VAL . 41.1 t -81.37 3.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.276 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.108 -179.518 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.291 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -60.73 -26.47 67.22 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -84.46 -27.14 27.71 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 112.634 -2.076 . . . . 0.0 108.686 178.655 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.656 ' O ' HG23 ' A' ' 11' ' ' VAL . 1.4 pttt -85.69 -17.84 34.84 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.554 ' N ' ' O ' ' A' ' 4' ' ' LEU . 8.1 mt -92.38 -29.57 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.702 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.695 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -72.77 -33.76 60.03 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.947 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -71.61 -31.47 66.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.958 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 7' ' ' LYS . 79.0 t -55.12 -31.88 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.695 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 31.9 tp -52.59 -35.27 53.89 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.623 -1.172 . . . . 0.0 108.351 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -75.93 -40.06 54.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.053 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.04 -9.04 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.882 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.46 HD13 HG12 ' A' ' 11' ' ' VAL . 2.0 tp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.212 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 7' ' ' LYS . 3.4 mt . . . . . 0 CA--C 1.493 -1.218 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.87 -34.7 60.17 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 111.614 -2.539 . . . . 0.0 107.889 177.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.48 -25.27 50.28 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.753 -2.022 . . . . 0.0 108.38 177.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.631 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -88.1 -8.24 55.77 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.212 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' A' ' 4' ' ' LEU . 5.9 mm -93.29 -30.55 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.316 0.579 . . . . 0.0 110.159 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.826 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -73.13 -32.21 60.72 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.041 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.09 -33.76 65.8 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.116 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 7' ' ' LYS . 96.5 t -55.79 -30.75 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.826 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 1.0 OUTLIER -53.85 -33.27 55.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.653 176.523 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 6.9 mtmm -79.33 -39.12 33.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.505 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 20.3 t -69.42 -18.72 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.387 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.344 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.437 -1.075 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -63.14 -22.22 66.72 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -86.81 -27.83 23.3 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 113.111 -1.859 . . . . 0.0 108.051 177.637 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.831 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -86.05 -7.88 58.31 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.436 177.471 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' LEU . 65.7 mt -95.39 -33.34 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.041 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.767 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -64.89 -36.45 93.11 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.163 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -75.21 -34.62 61.51 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.231 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 7' ' ' LYS . 84.9 t -55.84 -30.61 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.767 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -52.8 -34.75 54.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.383 176.482 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 10' ' ' ALA . 5.4 tptp -78.8 -39.53 35.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.05 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 2.6 t -74.49 -9.62 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.783 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 tp . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.235 -179.611 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.433 -1.277 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -62.06 -24.81 67.31 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.411 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 1.0 OUTLIER -84.71 -28.06 26.58 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 112.731 -2.031 . . . . 0.0 108.07 177.96 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.648 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -84.75 -12.25 54.11 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.386 177.178 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.566 ' N ' ' O ' ' A' ' 4' ' ' LEU . 43.0 mt -95.81 -32.76 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.227 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.805 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -70.28 -31.76 68.79 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.471 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -77.16 -37.94 52.77 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.633 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 7' ' ' LYS . 91.4 t -55.84 -30.2 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.805 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 14.3 tp -52.08 -37.03 52.62 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.506 -1.224 . . . . 0.0 107.887 176.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 4.1 mtmm -81.22 -31.91 33.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.405 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.568 ' CG1' HG13 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -79.01 7.07 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.715 -178.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.9 tp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.387 -179.142 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.137 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -61.57 -25.33 67.25 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.407 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -84.81 -27.72 26.61 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 112.86 -1.973 . . . . 0.0 108.477 178.153 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.628 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -86.21 -14.14 44.81 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.739 177.779 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' LEU . 40.4 mt -95.73 -31.21 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.739 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.775 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -69.5 -33.2 71.97 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.46 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -76.27 -38.35 56.35 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.477 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 7' ' ' LYS . 96.0 t -55.27 -31.06 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.775 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 48.1 tp -49.84 -37.01 28.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.111 176.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.0 mmpt? -80.89 -34.83 33.28 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.632 -1.622 . . . . 0.0 110.159 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.617 HG12 HG13 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -79.65 0.53 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.376 -179.482 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.12 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.588 ' O ' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.213 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -61.28 -25.26 66.98 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -83.87 -28.65 27.81 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 112.885 -1.962 . . . . 0.0 108.335 178.203 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.787 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -81.83 -17.09 48.65 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.291 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 4' ' ' LEU . 1.7 mp -99.48 -29.41 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.372 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.836 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -72.96 -33.14 60.03 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.95 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -77.05 -36.82 55.69 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.795 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 7' ' ' LYS . 94.5 t -56.54 -30.29 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.836 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 66.8 tp -52.08 -34.63 44.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.448 176.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 23.9 mtpp -81.73 -38.13 26.22 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.226 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.558 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 7.6 t -75.99 -7.69 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.965 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.732 HD13 HG12 ' A' ' 11' ' ' VAL . 1.4 tp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.12 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.437 -1.092 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -61.01 -25.94 67.25 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.6 OUTLIER -85.41 -26.84 26.16 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 112.721 -2.036 . . . . 0.0 108.669 178.346 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.807 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -88.05 -14.42 39.01 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.096 178.167 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 4' ' ' LEU . 44.8 mt -96.53 -30.41 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.811 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.836 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -74.88 -31.21 58.35 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.16 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -77.06 -34.41 57.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.388 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 7' ' ' LYS . 86.5 t -55.62 -31.36 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.836 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 68.5 mt -53.27 -35.54 60.18 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.305 176.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 10' ' ' ALA . 65.3 tttt -76.14 -40.14 53.42 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.046 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.04 -9.08 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.817 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.586 HD23 HG12 ' A' ' 11' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.098 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 8' ' ' ILE . 1.5 mp . . . . . 0 N--CA 1.436 -1.165 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -61.01 -25.69 67.08 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -83.85 -28.64 27.86 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 112.75 -2.023 . . . . 0.0 108.695 178.453 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.805 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -86.38 -13.73 45.52 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.736 177.878 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 4' ' ' LEU . 11.2 mt -94.48 -31.35 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.874 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.828 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -64.64 -37.28 94.18 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.297 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -75.67 -32.76 60.29 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.243 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 7' ' ' LYS . 68.0 t -56.37 -31.16 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.828 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 27.6 mt -52.86 -35.24 57.35 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.403 176.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 9.1 mttp -77.5 -40.16 43.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.14 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.424 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 1.9 t -75.81 -9.65 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.863 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.131 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.436 -1.164 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -61.17 -25.66 67.17 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 2.3 ptmt -85.43 -26.96 26.07 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 112.67 -2.059 . . . . 0.0 108.639 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.711 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -86.88 -16.39 36.16 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.928 177.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.587 ' N ' ' O ' ' A' ' 4' ' ' LEU . 24.9 mt -94.3 -31.05 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.716 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.729 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -72.06 -33.25 62.5 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.95 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.22 -33.46 65.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.102 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 7' ' ' LYS . 66.0 t -55.43 -30.23 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.729 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 46.7 tp -53.61 -35.2 60.64 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.404 176.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 7.8 mmtt -77.22 -39.82 47.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.095 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 1.1 t -75.86 -9.3 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.795 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.444 HD13 HG12 ' A' ' 11' ' ' VAL . 2.2 tp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.132 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.686 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 121.518 0.675 . . . . 0.0 111.505 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.748 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.79 -107.32 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 118.363 2.727 . . . . 0.0 118.363 -176.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -91.44 -10.75 39.82 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 121.937 0.875 . . . . 0.0 112.601 -175.667 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.637 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -98.38 -25.31 14.86 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.483 177.268 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.686 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 23.4 t80 -61.21 -25.82 67.31 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -85.49 -26.79 26.07 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 112.691 -2.049 . . . . 0.0 108.664 178.404 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.696 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -87.55 -16.12 35.51 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.002 178.095 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.598 ' N ' ' O ' ' A' ' 4' ' ' LEU . 6.8 mt -93.73 -30.86 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.84 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.686 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -68.97 -34.95 77.78 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.11 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -73.32 -33.01 64.92 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.258 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 7' ' ' LYS . 76.4 t -54.9 -32.25 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.686 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 28.6 tp -51.45 -36.45 44.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.06 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 10' ' ' ALA . 4.1 tttt -77.13 -36.31 55.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.037 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.59 -6.58 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.146 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.115 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.67 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 11.4 pttp . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.461 0.648 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.746 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.09 -107.14 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -176.604 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 44.9 mtmt -91.5 -10.39 40.97 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 121.956 0.884 . . . . 0.0 112.745 -175.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.63 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -98.31 -25.77 14.73 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.426 177.266 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.67 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 28.4 t80 -61.55 -25.49 67.33 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 176.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -86.16 -26.13 25.32 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 112.695 -2.048 . . . . 0.0 108.652 178.318 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.746 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -87.51 -16.39 34.82 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.891 178.093 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.586 ' N ' ' O ' ' A' ' 4' ' ' LEU . 10.5 mt -95.36 -30.01 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.802 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.72 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -74.32 -32.36 58.14 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.965 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.91 -34.54 64.41 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.086 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 7' ' ' LYS . 63.9 t -55.02 -32.03 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.72 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 5.2 tp -50.06 -36.96 31.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.234 176.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 34.7 mmtm -78.53 -36.22 45.11 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.147 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -78.91 -2.76 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.313 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.645 HD13 HG12 ' A' ' 11' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.1 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.668 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.383 0.611 . . . . 0.0 111.587 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.759 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.03 -107.0 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 118.437 2.754 . . . . 0.0 118.437 -176.6 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.53 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 16.0 tttt -91.8 -9.69 42.62 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.952 0.882 . . . . 0.0 112.804 -175.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.656 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.9 OUTLIER -98.18 -26.99 14.37 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.197 177.114 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.668 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 32.0 t80 -61.4 -24.97 66.88 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 176.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -85.51 -26.98 25.91 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 112.87 -1.968 . . . . 0.0 108.712 178.452 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HG2' ' HG ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.22 -15.71 35.22 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.937 178.108 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.561 ' N ' ' O ' ' A' ' 4' ' ' LEU . 48.5 mt -94.09 -30.92 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.871 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.652 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -68.32 -34.89 81.23 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.234 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -75.41 -31.96 60.59 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.32 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -31.62 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.652 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -54.17 -42.69 69.91 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.264 176.427 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 10' ' ' ALA . 14.9 ttmt -65.83 -38.48 89.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.4 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.07 -8.65 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.805 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.072 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.689 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.276 0.56 . . . . 0.0 111.551 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.764 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.9 -107.97 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 118.364 2.727 . . . . 0.0 118.364 -176.678 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.615 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 13.3 mmtt -90.96 -11.3 39.4 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 122.07 0.938 . . . . 0.0 112.36 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.811 HD23 ' HB3' ' A' ' 7' ' ' LYS . 3.5 mt -98.27 -25.61 14.8 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-N 114.198 -1.364 . . . . 0.0 108.797 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.689 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 44.1 t80 -63.17 -23.76 67.58 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.615 ' HG2' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -83.93 -27.75 28.34 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 113.07 -1.877 . . . . 0.0 107.852 177.707 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.811 ' HB3' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -84.6 -12.73 53.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.205 177.08 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 4' ' ' LEU . 12.2 mt -95.0 -28.92 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.417 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.895 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -72.25 -33.65 61.65 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -74.23 -31.37 62.57 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.466 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 7' ' ' LYS . 96.0 t -56.6 -29.71 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.895 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 62.7 mt -57.04 -31.39 65.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.379 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -79.7 -38.91 32.45 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.505 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.18 -20.69 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.333 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.194 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.696 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 4.1 pttp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.257 0.551 . . . . 0.0 111.925 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.755 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -77.12 -107.37 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 118.48 2.77 . . . . 0.0 118.48 -176.634 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.545 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -91.01 -10.83 40.8 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 121.931 0.872 . . . . 0.0 112.621 -175.647 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.659 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -98.49 -25.07 14.89 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.585 177.196 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.696 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 37.1 t80 -61.38 -25.69 67.34 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -84.3 -28.8 26.88 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 112.721 -2.036 . . . . 0.0 108.395 178.104 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.431 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -85.87 -9.37 57.08 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.55 177.552 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.556 ' N ' ' O ' ' A' ' 4' ' ' LEU . 14.8 mm -94.64 -33.61 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.666 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.687 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -61.37 -39.33 97.11 Favored Glycine 0 C--N 1.314 -0.657 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.599 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -75.83 -28.41 58.26 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.177 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.21 -32.42 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.687 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 61.9 mt -54.11 -42.66 69.67 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.077 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 27.4 mttp -67.79 -34.53 76.96 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.827 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -78.51 -5.85 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.076 -179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.061 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.547 ' CB ' ' HB2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.736 0.303 . . . . 0.0 111.601 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.73 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -75.04 -106.91 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 119.408 3.114 . . . . 0.0 119.408 -175.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 7.5 mtpp -90.19 -10.79 43.11 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.995 0.902 . . . . 0.0 112.866 -174.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.784 HD23 ' HB3' ' A' ' 7' ' ' LYS . 1.0 OUTLIER -98.35 -25.42 14.83 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.464 177.368 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.547 ' HB2' ' CB ' ' A' ' 1' ' ' LYS . 19.3 t80 -60.41 -26.51 66.75 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.542 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -84.07 -28.2 27.74 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 112.623 -2.08 . . . . 0.0 108.649 178.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.784 ' HB3' HD23 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -84.36 -16.91 41.19 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.648 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.548 ' N ' ' O ' ' A' ' 4' ' ' LEU . 24.1 mt -89.63 -33.96 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.617 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.86 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -68.99 -34.9 77.58 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.586 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -69.31 -29.02 66.78 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.946 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 7' ' ' LYS . 61.4 t -54.75 -33.94 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.86 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 2.8 mm? -51.69 -34.89 40.59 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.473 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.586 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 20.4 mttm -76.71 -38.15 54.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.991 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 2.2 t -76.12 -9.64 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.708 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.049 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 5' ' ' PHE . 3.2 ptpp? . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.268 0.556 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.921 ' CH2' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.33 -95.17 0.1 Allowed 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -178.14 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.784 ' N ' ' HE3' ' A' ' 2' ' ' TRP . 0.1 OUTLIER -80.15 4.38 17.58 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 121.643 0.735 . . . . 0.0 111.883 -179.35 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.921 HD22 ' CH2' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -93.39 -45.9 7.59 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 177.145 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.599 ' HB2' ' O ' ' A' ' 1' ' ' LYS . 0.2 OUTLIER -51.29 -34.11 31.65 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 111.711 -2.495 . . . . 0.0 108.159 177.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER -80.26 -25.48 39.47 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 112.503 -2.135 . . . . 0.0 109.102 178.06 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 4' ' ' LEU . 12.2 ttpt -89.05 -12.19 41.99 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.374 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' LEU . 26.7 mt -89.25 -30.63 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.507 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.742 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -70.43 -35.22 68.58 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -68.63 -30.46 69.18 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.863 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 7' ' ' LYS . 83.7 t -55.56 -32.2 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.742 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 81.0 mt -50.38 -36.26 31.79 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 56.0 mttt -78.83 -36.52 42.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.751 -1.568 . . . . 0.0 110.308 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -78.59 -4.65 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.157 -179.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.135 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.601 ' O ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 121.429 0.633 . . . . 0.0 111.478 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.917 ' CH2' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.78 -95.85 0.1 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -178.032 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.803 ' N ' ' HE3' ' A' ' 2' ' ' TRP . 3.5 mptp? -80.05 4.79 16.01 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-O 121.584 0.707 . . . . 0.0 111.894 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.917 HD22 ' CH2' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -93.07 -48.26 6.58 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.038 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.601 ' HB2' ' O ' ' A' ' 1' ' ' LYS . 0.3 OUTLIER -51.54 -35.55 41.32 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 111.521 -2.581 . . . . 0.0 107.733 177.374 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.503 ' HG2' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -76.0 -26.44 56.71 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 112.531 -2.122 . . . . 0.0 108.939 177.738 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.697 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -88.98 -10.61 47.01 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.56 178.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 4' ' ' LEU . 22.8 mt -92.94 -29.27 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.617 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.784 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -73.33 -33.59 58.7 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -72.6 -31.4 65.16 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.142 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 7' ' ' LYS . 81.7 t -55.71 -31.48 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 177.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.784 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 59.5 mt -52.82 -35.45 57.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.358 176.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 3.9 mmpp? -76.72 -39.09 53.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.063 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.406 ' O ' ' CG1' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -76.75 -8.43 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.896 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.136 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.69 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.033 0.444 . . . . 0.0 111.526 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.751 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -78.16 -108.26 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 118.515 2.783 . . . . 0.0 118.515 -176.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 10.1 ttpp -91.9 -10.82 38.19 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 122.077 0.941 . . . . 0.0 112.676 -175.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.678 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 1.4 mp -97.99 -26.65 14.56 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.354 -1.293 . . . . 0.0 108.215 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.69 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 32.9 t80 -61.27 -24.89 66.72 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 176.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -85.62 -27.2 25.6 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 112.778 -2.01 . . . . 0.0 108.84 178.613 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.716 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -90.76 -13.4 34.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.268 178.256 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 4' ' ' LEU . 46.1 mt -94.21 -32.61 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.751 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.725 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -73.9 -31.19 60.37 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.149 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.68 -34.93 65.11 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.969 -0.693 . . . . 0.0 110.161 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 7' ' ' LYS . 72.9 t -55.17 -31.23 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.725 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 29.2 tp -50.86 -36.86 39.9 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.123 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.2 mmtp -78.55 -36.29 44.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.154 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -78.46 -3.61 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.323 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.077 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.677 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.125 0.488 . . . . 0.0 112.196 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.749 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.39 -107.18 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 118.531 2.789 . . . . 0.0 118.531 -176.451 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 4.6 ttpt -91.32 -10.67 40.45 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.921 0.867 . . . . 0.0 112.71 -175.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.629 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 1.3 mp -98.16 -26.37 14.59 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.441 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.677 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 34.7 t80 -61.3 -25.27 67.01 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -85.53 -26.75 26.01 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 112.776 -2.011 . . . . 0.0 108.702 178.453 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.588 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -86.72 -16.49 36.28 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.677 177.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.553 ' N ' ' O ' ' A' ' 4' ' ' LEU . 72.4 mt -95.39 -31.08 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.956 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.799 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -76.43 -29.06 58.67 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.609 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -77.31 -38.63 50.15 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.736 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 7' ' ' LYS . 89.0 t -55.63 -31.36 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.799 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 2.6 tm? -51.77 -33.61 35.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.348 -1.297 . . . . 0.0 108.739 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -83.75 -35.72 24.17 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.343 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 14' ' ' VAL . 41.1 t -81.37 3.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.276 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.108 -179.518 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.539 ' CB ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.881 0.372 . . . . 0.0 111.732 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.75 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -74.57 -106.6 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 119.165 3.024 . . . . 0.0 119.165 -176.322 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 9.8 mttt -91.27 -8.89 47.03 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 121.841 0.829 . . . . 0.0 112.844 -175.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.658 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -98.35 -26.17 14.58 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.172 176.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.539 ' HB2' ' CB ' ' A' ' 1' ' ' LYS . 21.2 t80 -60.73 -26.47 67.22 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.54 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -84.46 -27.14 27.71 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 112.634 -2.076 . . . . 0.0 108.686 178.655 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.656 ' O ' HG23 ' A' ' 11' ' ' VAL . 1.4 pttt -85.69 -17.84 34.84 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.554 ' N ' ' O ' ' A' ' 4' ' ' LEU . 8.1 mt -92.38 -29.57 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.702 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.695 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -72.77 -33.76 60.03 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.947 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -71.61 -31.47 66.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.958 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 7' ' ' LYS . 79.0 t -55.12 -31.88 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.695 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 31.9 tp -52.59 -35.27 53.89 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.623 -1.172 . . . . 0.0 108.351 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -75.93 -40.06 54.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.053 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.04 -9.04 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.882 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.46 HD13 HG12 ' A' ' 11' ' ' VAL . 2.0 tp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.212 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.628 ' O ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.224 0.535 . . . . 0.0 111.662 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.811 ' HE3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -89.22 -94.87 0.1 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -178.169 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.811 ' N ' ' HE3' ' A' ' 2' ' ' TRP . 0.1 OUTLIER -79.9 5.04 14.85 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 121.726 0.774 . . . . 0.0 111.867 -179.444 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.759 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 3.4 mt -94.65 -47.39 6.53 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 177.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.628 ' HB2' ' O ' ' A' ' 1' ' ' LYS . 0.3 OUTLIER -53.87 -34.7 60.17 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 111.614 -2.539 . . . . 0.0 107.889 177.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -77.48 -25.27 50.28 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.753 -2.022 . . . . 0.0 108.38 177.378 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.631 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -88.1 -8.24 55.77 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.212 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' A' ' 4' ' ' LEU . 5.9 mm -93.29 -30.55 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.316 0.579 . . . . 0.0 110.159 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.826 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -73.13 -32.21 60.72 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.041 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.09 -33.76 65.8 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.116 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 7' ' ' LYS . 96.5 t -55.79 -30.75 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.826 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 1.0 OUTLIER -53.85 -33.27 55.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.653 176.523 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 6.9 mtmm -79.33 -39.12 33.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.505 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 20.3 t -69.42 -18.72 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.387 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.344 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.694 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 2.4 pttp . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.46 0.647 . . . . 0.0 111.623 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.747 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.67 -105.95 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 119.052 2.982 . . . . 0.0 119.052 -176.249 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.507 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 8.1 mmtp -89.64 -13.06 37.87 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.856 0.836 . . . . 0.0 112.736 -175.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.611 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -98.16 -27.09 14.34 Favored 'General case' 0 C--N 1.284 -2.283 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.062 177.859 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.694 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 76.7 t80 -63.14 -22.22 66.72 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -86.81 -27.83 23.3 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 113.111 -1.859 . . . . 0.0 108.051 177.637 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.831 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -86.05 -7.88 58.31 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.436 177.471 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' LEU . 65.7 mt -95.39 -33.34 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.041 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.767 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -64.89 -36.45 93.11 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.163 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -75.21 -34.62 61.51 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.231 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 7' ' ' LYS . 84.9 t -55.84 -30.61 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.767 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -52.8 -34.75 54.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.383 176.482 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 10' ' ' ALA . 5.4 tptp -78.8 -39.53 35.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.05 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 2.6 t -74.49 -9.62 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.783 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 tp . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.235 -179.611 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.591 ' CB ' ' HB2' ' A' ' 5' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 120.846 0.355 . . . . 0.0 111.838 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.713 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -74.22 -107.41 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 119.432 3.123 . . . . 0.0 119.432 -175.718 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.561 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 74.9 mttt -91.01 -9.7 44.97 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 122.025 0.917 . . . . 0.0 112.739 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.679 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.1 OUTLIER -98.95 -24.75 14.82 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.399 176.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.591 ' HB2' ' CB ' ' A' ' 1' ' ' LYS . 41.9 t80 -62.06 -24.81 67.31 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 3' ' ' LYS . 1.0 OUTLIER -84.71 -28.06 26.58 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 112.731 -2.031 . . . . 0.0 108.07 177.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.648 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -84.75 -12.25 54.11 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.386 177.178 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.566 ' N ' ' O ' ' A' ' 4' ' ' LEU . 43.0 mt -95.81 -32.76 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.227 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.805 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -70.28 -31.76 68.79 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.471 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -77.16 -37.94 52.77 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.633 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 7' ' ' LYS . 91.4 t -55.84 -30.2 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.805 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 14.3 tp -52.08 -37.03 52.62 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.506 -1.224 . . . . 0.0 107.887 176.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 4.1 mtmm -81.22 -31.91 33.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.405 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.568 ' CG1' HG13 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -79.01 7.07 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.715 -178.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.9 tp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.387 -179.142 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.694 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.437 0.637 . . . . 0.0 111.467 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.748 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.5 -107.09 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 118.479 2.77 . . . . 0.0 118.479 -176.644 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.539 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 14.8 mtpp -90.95 -11.11 40.01 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 122.035 0.922 . . . . 0.0 112.625 -175.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.638 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -98.28 -25.36 14.88 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.679 177.281 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.694 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 33.2 t80 -61.57 -25.33 67.25 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.539 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -84.81 -27.72 26.61 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 112.86 -1.973 . . . . 0.0 108.477 178.153 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.628 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -86.21 -14.14 44.81 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.739 177.779 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' LEU . 40.4 mt -95.73 -31.21 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.739 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.775 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -69.5 -33.2 71.97 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.46 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -76.27 -38.35 56.35 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.477 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 7' ' ' LYS . 96.0 t -55.27 -31.06 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.775 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 48.1 tp -49.84 -37.01 28.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.111 176.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.0 mmpt? -80.89 -34.83 33.28 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.632 -1.622 . . . . 0.0 110.159 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.617 HG12 HG13 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -79.65 0.53 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.376 -179.482 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.12 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.685 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.458 0.647 . . . . 0.0 111.571 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.761 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -77.99 -107.31 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 118.553 2.797 . . . . 0.0 118.553 -176.484 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.57 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -91.17 -11.2 39.1 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.054 0.93 . . . . 0.0 112.523 -175.754 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.654 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -98.34 -25.67 14.75 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.606 177.252 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.685 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 27.3 t80 -61.28 -25.26 66.98 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 176.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -83.87 -28.65 27.81 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 112.885 -1.962 . . . . 0.0 108.335 178.203 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.787 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -81.83 -17.09 48.65 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.291 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 4' ' ' LEU . 1.7 mp -99.48 -29.41 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.372 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.836 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -72.96 -33.14 60.03 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.95 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -77.05 -36.82 55.69 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.795 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 7' ' ' LYS . 94.5 t -56.54 -30.29 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.836 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 66.8 tp -52.08 -34.63 44.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.448 176.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 23.9 mtpp -81.73 -38.13 26.22 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.226 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.558 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 7.6 t -75.99 -7.69 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.965 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.732 HD13 HG12 ' A' ' 11' ' ' VAL . 1.4 tp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.12 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.674 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 18.6 pttm . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.523 0.677 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.753 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.03 -107.04 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 118.375 2.731 . . . . 0.0 118.375 -176.627 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.53 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 0.2 OUTLIER -91.54 -10.27 41.25 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.846 0.832 . . . . 0.0 112.593 -175.754 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.631 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.1 OUTLIER -98.37 -25.72 14.73 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.442 177.175 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.674 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 25.6 t80 -61.01 -25.94 67.25 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -85.41 -26.84 26.16 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 112.721 -2.036 . . . . 0.0 108.669 178.346 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.807 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -88.05 -14.42 39.01 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.096 178.167 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 4' ' ' LEU . 44.8 mt -96.53 -30.41 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.811 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.836 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -74.88 -31.21 58.35 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.16 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -77.06 -34.41 57.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.388 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 7' ' ' LYS . 86.5 t -55.62 -31.36 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.836 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 68.5 mt -53.27 -35.54 60.18 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.305 176.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 10' ' ' ALA . 65.3 tttt -76.14 -40.14 53.42 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.046 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.04 -9.08 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.817 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.586 HD23 HG12 ' A' ' 11' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.098 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.695 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.142 0.496 . . . . 0.0 111.705 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.766 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -77.86 -107.95 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 118.32 2.711 . . . . 0.0 118.32 -176.73 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.551 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -91.96 -10.65 38.62 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.094 0.95 . . . . 0.0 112.554 -175.751 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.692 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 1.5 mp -98.2 -25.96 14.71 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.272 177.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.695 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 28.3 t80 -61.01 -25.69 67.08 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 176.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.551 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -83.85 -28.64 27.86 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 112.75 -2.023 . . . . 0.0 108.695 178.453 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.805 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -86.38 -13.73 45.52 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.736 177.878 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 4' ' ' LEU . 11.2 mt -94.48 -31.35 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.874 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.828 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -64.64 -37.28 94.18 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.297 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -75.67 -32.76 60.29 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.243 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 7' ' ' LYS . 68.0 t -56.37 -31.16 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.828 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 27.6 mt -52.86 -35.24 57.35 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.403 176.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 9.1 mttp -77.5 -40.16 43.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.14 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.424 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 1.9 t -75.81 -9.65 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.863 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.131 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.672 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 6.9 pttt . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.46 0.648 . . . . 0.0 111.481 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.759 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.28 -107.0 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 -176.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.525 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 0.2 OUTLIER -91.39 -10.06 42.46 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.986 0.898 . . . . 0.0 112.663 -175.736 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.63 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.1 OUTLIER -98.36 -25.86 14.68 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.452 177.15 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.672 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 28.3 t80 -61.17 -25.66 67.17 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 2.3 ptmt -85.43 -26.96 26.07 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 112.67 -2.059 . . . . 0.0 108.639 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.711 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -86.88 -16.39 36.16 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.928 177.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.587 ' N ' ' O ' ' A' ' 4' ' ' LEU . 24.9 mt -94.3 -31.05 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.716 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.729 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -72.06 -33.25 62.5 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.95 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.22 -33.46 65.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.102 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 7' ' ' LYS . 66.0 t -55.43 -30.23 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.729 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 46.7 tp -53.61 -35.2 60.64 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.404 176.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 7.8 mmtt -77.22 -39.82 47.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.095 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 1.1 t -75.86 -9.3 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.795 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.444 HD13 HG12 ' A' ' 11' ' ' VAL . 2.2 tp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.132 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.09 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -61.21 -25.82 67.31 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -85.49 -26.79 26.07 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 112.691 -2.049 . . . . 0.0 108.664 178.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.696 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -87.55 -16.12 35.51 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.002 178.095 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.598 ' N ' ' O ' ' A' ' 4' ' ' LEU . 6.8 mt -93.73 -30.86 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.84 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.686 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -68.97 -34.95 77.78 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.11 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -73.32 -33.01 64.92 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.258 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 7' ' ' LYS . 76.4 t -54.9 -32.25 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.686 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 28.6 tp -51.45 -36.45 44.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.06 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 10' ' ' ALA . 4.1 tttt -77.13 -36.31 55.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.037 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.59 -6.58 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.146 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.115 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.165 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -61.55 -25.49 67.33 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.16 -26.13 25.32 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 112.695 -2.048 . . . . 0.0 108.652 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.746 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -87.51 -16.39 34.82 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.891 178.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.586 ' N ' ' O ' ' A' ' 4' ' ' LEU . 10.5 mt -95.36 -30.01 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.802 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.72 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -74.32 -32.36 58.14 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.965 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.91 -34.54 64.41 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.086 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 7' ' ' LYS . 63.9 t -55.02 -32.03 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.72 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 5.2 tp -50.06 -36.96 31.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.234 176.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 34.7 mmtm -78.53 -36.22 45.11 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.147 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -78.91 -2.76 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.313 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.645 HD13 HG12 ' A' ' 11' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.1 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.435 -1.195 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.4 -24.97 66.88 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -85.51 -26.98 25.91 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 112.87 -1.968 . . . . 0.0 108.712 178.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HG2' ' HG ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.22 -15.71 35.22 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.937 178.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.561 ' N ' ' O ' ' A' ' 4' ' ' LEU . 48.5 mt -94.09 -30.92 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.871 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.652 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -68.32 -34.89 81.23 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.234 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -75.41 -31.96 60.59 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.32 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -31.62 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.652 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -54.17 -42.69 69.91 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.264 176.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 10' ' ' ALA . 14.9 ttmt -65.83 -38.48 89.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.4 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.07 -8.65 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.805 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.072 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.811 HD23 ' HB3' ' A' ' 7' ' ' LYS . 3.5 mt . . . . . 0 N--CA 1.433 -1.323 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -63.17 -23.76 67.58 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.93 -27.75 28.34 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 113.07 -1.877 . . . . 0.0 107.852 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.811 ' HB3' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -84.6 -12.73 53.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.205 177.08 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 4' ' ' LEU . 12.2 mt -95.0 -28.92 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.417 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.895 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -72.25 -33.65 61.65 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -74.23 -31.37 62.57 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.466 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 7' ' ' LYS . 96.0 t -56.6 -29.71 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.895 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 62.7 mt -57.04 -31.39 65.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.379 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -79.7 -38.91 32.45 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.505 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.18 -20.69 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.333 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.194 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.249 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -61.38 -25.69 67.34 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.7 OUTLIER -84.3 -28.8 26.88 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 112.721 -2.036 . . . . 0.0 108.395 178.104 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.431 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -85.87 -9.37 57.08 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.55 177.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.556 ' N ' ' O ' ' A' ' 4' ' ' LEU . 14.8 mm -94.64 -33.61 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.666 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.687 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -61.37 -39.33 97.11 Favored Glycine 0 C--N 1.314 -0.657 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.599 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -75.83 -28.41 58.26 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.177 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.21 -32.42 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.687 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 61.9 mt -54.11 -42.66 69.67 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.077 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 27.4 mttp -67.79 -34.53 76.96 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.827 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -78.51 -5.85 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.076 -179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.061 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.784 HD23 ' HB3' ' A' ' 7' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.433 -1.279 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -60.41 -26.51 66.75 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 176.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -84.07 -28.2 27.74 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 112.623 -2.08 . . . . 0.0 108.649 178.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.784 ' HB3' HD23 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -84.36 -16.91 41.19 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.548 ' N ' ' O ' ' A' ' 4' ' ' LEU . 24.1 mt -89.63 -33.96 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.617 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.86 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -68.99 -34.9 77.58 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.586 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -69.31 -29.02 66.78 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.946 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 7' ' ' LYS . 61.4 t -54.75 -33.94 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.86 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 2.8 mm? -51.69 -34.89 40.59 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.473 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.586 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 20.4 mttm -76.71 -38.15 54.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.991 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 2.2 t -76.12 -9.64 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.708 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.049 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.494 -1.193 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -34.11 31.65 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 111.711 -2.495 . . . . 0.0 108.159 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.26 -25.48 39.47 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 112.503 -2.135 . . . . 0.0 109.102 178.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 4' ' ' LEU . 12.2 ttpt -89.05 -12.19 41.99 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.374 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' LEU . 26.7 mt -89.25 -30.63 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.507 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.742 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -70.43 -35.22 68.58 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -68.63 -30.46 69.18 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.863 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 7' ' ' LYS . 83.7 t -55.56 -32.2 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.742 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 81.0 mt -50.38 -36.26 31.79 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 56.0 mttt -78.83 -36.52 42.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.751 -1.568 . . . . 0.0 110.308 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -78.59 -4.65 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.157 -179.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.135 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.609 ' O ' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.493 -1.23 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.54 -35.55 41.32 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 111.521 -2.581 . . . . 0.0 107.733 177.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -76.0 -26.44 56.71 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 112.531 -2.122 . . . . 0.0 108.939 177.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.697 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -88.98 -10.61 47.01 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.56 178.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 4' ' ' LEU . 22.8 mt -92.94 -29.27 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.617 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.784 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -73.33 -33.59 58.7 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -72.6 -31.4 65.16 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.142 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 7' ' ' LYS . 81.7 t -55.71 -31.48 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 177.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.784 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 59.5 mt -52.82 -35.45 57.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.358 176.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 3.9 mmpp? -76.72 -39.09 53.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.063 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.406 ' O ' ' CG1' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -76.75 -8.43 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.896 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.136 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 8' ' ' ILE . 1.4 mp . . . . . 0 N--CA 1.434 -1.231 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -61.27 -24.89 66.72 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -85.62 -27.2 25.6 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 112.778 -2.01 . . . . 0.0 108.84 178.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.716 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -90.76 -13.4 34.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.268 178.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 4' ' ' LEU . 46.1 mt -94.21 -32.61 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.751 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.725 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -73.9 -31.19 60.37 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.149 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.68 -34.93 65.11 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.969 -0.693 . . . . 0.0 110.161 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 7' ' ' LYS . 72.9 t -55.17 -31.23 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.725 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 29.2 tp -50.86 -36.86 39.9 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.123 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.2 mmtp -78.55 -36.29 44.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.154 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -78.46 -3.61 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.323 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.077 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 8' ' ' ILE . 1.3 mp . . . . . 0 N--CA 1.437 -1.111 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -61.3 -25.27 67.01 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.53 -26.75 26.01 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 112.776 -2.011 . . . . 0.0 108.702 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.588 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -86.72 -16.49 36.28 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.677 177.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.553 ' N ' ' O ' ' A' ' 4' ' ' LEU . 72.4 mt -95.39 -31.08 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.956 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.799 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -76.43 -29.06 58.67 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.609 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -77.31 -38.63 50.15 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.736 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 7' ' ' LYS . 89.0 t -55.63 -31.36 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.799 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 2.6 tm? -51.77 -33.61 35.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.348 -1.297 . . . . 0.0 108.739 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -83.75 -35.72 24.17 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.343 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.574 ' O ' HG12 ' A' ' 14' ' ' VAL . 41.1 t -81.37 3.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.276 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.108 -179.518 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.291 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -60.73 -26.47 67.22 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -84.46 -27.14 27.71 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 112.634 -2.076 . . . . 0.0 108.686 178.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.656 ' O ' HG23 ' A' ' 11' ' ' VAL . 1.4 pttt -85.69 -17.84 34.84 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.554 ' N ' ' O ' ' A' ' 4' ' ' LEU . 8.1 mt -92.38 -29.57 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.702 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.695 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -72.77 -33.76 60.03 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.947 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -71.61 -31.47 66.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.958 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 7' ' ' LYS . 79.0 t -55.12 -31.88 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.695 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 31.9 tp -52.59 -35.27 53.89 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.623 -1.172 . . . . 0.0 108.351 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -75.93 -40.06 54.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.053 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.04 -9.04 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.882 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.46 HD13 HG12 ' A' ' 11' ' ' VAL . 2.0 tp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.212 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 7' ' ' LYS . 3.4 mt . . . . . 0 CA--C 1.493 -1.218 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.87 -34.7 60.17 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 111.614 -2.539 . . . . 0.0 107.889 177.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.48 -25.27 50.28 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.753 -2.022 . . . . 0.0 108.38 177.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.631 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -88.1 -8.24 55.77 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.212 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' A' ' 4' ' ' LEU . 5.9 mm -93.29 -30.55 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.316 0.579 . . . . 0.0 110.159 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.826 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -73.13 -32.21 60.72 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.041 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.09 -33.76 65.8 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.116 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 7' ' ' LYS . 96.5 t -55.79 -30.75 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.826 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 1.0 OUTLIER -53.85 -33.27 55.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.653 176.523 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 6.9 mtmm -79.33 -39.12 33.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.505 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 20.3 t -69.42 -18.72 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.387 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.344 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.437 -1.075 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -63.14 -22.22 66.72 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -86.81 -27.83 23.3 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 113.111 -1.859 . . . . 0.0 108.051 177.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.831 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -86.05 -7.88 58.31 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.436 177.471 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' LEU . 65.7 mt -95.39 -33.34 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.041 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.767 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -64.89 -36.45 93.11 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.163 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -75.21 -34.62 61.51 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.231 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 7' ' ' LYS . 84.9 t -55.84 -30.61 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.767 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -52.8 -34.75 54.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.383 176.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 10' ' ' ALA . 5.4 tptp -78.8 -39.53 35.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.05 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 2.6 t -74.49 -9.62 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.783 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 tp . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.235 -179.611 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.433 -1.277 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -62.06 -24.81 67.31 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.411 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 1.0 OUTLIER -84.71 -28.06 26.58 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 112.731 -2.031 . . . . 0.0 108.07 177.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.648 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -84.75 -12.25 54.11 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.386 177.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.566 ' N ' ' O ' ' A' ' 4' ' ' LEU . 43.0 mt -95.81 -32.76 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.227 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.805 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -70.28 -31.76 68.79 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.471 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -77.16 -37.94 52.77 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.633 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 7' ' ' LYS . 91.4 t -55.84 -30.2 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.805 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 14.3 tp -52.08 -37.03 52.62 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.506 -1.224 . . . . 0.0 107.887 176.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 4.1 mtmm -81.22 -31.91 33.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.405 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.568 ' CG1' HG13 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -79.01 7.07 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.715 -178.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.9 tp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.387 -179.142 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.137 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -61.57 -25.33 67.25 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.407 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -84.81 -27.72 26.61 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 112.86 -1.973 . . . . 0.0 108.477 178.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.628 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -86.21 -14.14 44.81 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.739 177.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' LEU . 40.4 mt -95.73 -31.21 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.739 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.775 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -69.5 -33.2 71.97 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.46 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -76.27 -38.35 56.35 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.477 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 7' ' ' LYS . 96.0 t -55.27 -31.06 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.775 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 48.1 tp -49.84 -37.01 28.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.111 176.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.0 mmpt? -80.89 -34.83 33.28 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.632 -1.622 . . . . 0.0 110.159 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.617 HG12 HG13 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -79.65 0.53 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.376 -179.482 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.12 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.588 ' O ' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.213 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -61.28 -25.26 66.98 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -83.87 -28.65 27.81 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 112.885 -1.962 . . . . 0.0 108.335 178.203 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.787 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -81.83 -17.09 48.65 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.291 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 4' ' ' LEU . 1.7 mp -99.48 -29.41 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.372 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.836 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -72.96 -33.14 60.03 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.95 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -77.05 -36.82 55.69 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.795 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 7' ' ' LYS . 94.5 t -56.54 -30.29 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.836 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 66.8 tp -52.08 -34.63 44.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.448 176.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 23.9 mtpp -81.73 -38.13 26.22 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.226 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.558 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 7.6 t -75.99 -7.69 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.965 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.732 HD13 HG12 ' A' ' 11' ' ' VAL . 1.4 tp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.12 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.437 -1.092 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -61.01 -25.94 67.25 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.6 OUTLIER -85.41 -26.84 26.16 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 112.721 -2.036 . . . . 0.0 108.669 178.346 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.807 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -88.05 -14.42 39.01 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.096 178.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 4' ' ' LEU . 44.8 mt -96.53 -30.41 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.811 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.836 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -74.88 -31.21 58.35 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.16 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -77.06 -34.41 57.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.388 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 7' ' ' LYS . 86.5 t -55.62 -31.36 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.836 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 68.5 mt -53.27 -35.54 60.18 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.305 176.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 10' ' ' ALA . 65.3 tttt -76.14 -40.14 53.42 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.046 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.04 -9.08 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.817 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.586 HD23 HG12 ' A' ' 11' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.098 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 8' ' ' ILE . 1.5 mp . . . . . 0 N--CA 1.436 -1.165 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -61.01 -25.69 67.08 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -83.85 -28.64 27.86 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 112.75 -2.023 . . . . 0.0 108.695 178.453 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.805 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -86.38 -13.73 45.52 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.736 177.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 4' ' ' LEU . 11.2 mt -94.48 -31.35 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.874 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.828 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -64.64 -37.28 94.18 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.297 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -75.67 -32.76 60.29 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.243 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 7' ' ' LYS . 68.0 t -56.37 -31.16 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.828 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 27.6 mt -52.86 -35.24 57.35 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.403 176.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 9.1 mttp -77.5 -40.16 43.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.14 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.424 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 1.9 t -75.81 -9.65 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.863 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.131 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.436 -1.164 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -61.17 -25.66 67.17 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 7' ' ' LYS . 2.3 ptmt -85.43 -26.96 26.07 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 112.67 -2.059 . . . . 0.0 108.639 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.711 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -86.88 -16.39 36.16 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.928 177.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.587 ' N ' ' O ' ' A' ' 4' ' ' LEU . 24.9 mt -94.3 -31.05 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.716 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.729 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -72.06 -33.25 62.5 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.95 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.22 -33.46 65.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.102 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 7' ' ' LYS . 66.0 t -55.43 -30.23 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.729 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 46.7 tp -53.61 -35.2 60.64 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.404 176.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 7.8 mmtt -77.22 -39.82 47.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.095 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 1.1 t -75.86 -9.3 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.795 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.444 HD13 HG12 ' A' ' 11' ' ' VAL . 2.2 tp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.132 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.686 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 121.518 0.675 . . . . 0.0 111.505 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.748 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.79 -107.32 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 118.363 2.727 . . . . 0.0 118.363 -176.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -91.44 -10.75 39.82 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 121.937 0.875 . . . . 0.0 112.601 -175.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.637 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -98.38 -25.31 14.86 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.483 177.268 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.686 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 23.4 t80 -61.21 -25.82 67.31 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -85.49 -26.79 26.07 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 112.691 -2.049 . . . . 0.0 108.664 178.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.696 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -87.55 -16.12 35.51 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.002 178.095 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.598 ' N ' ' O ' ' A' ' 4' ' ' LEU . 6.8 mt -93.73 -30.86 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.84 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.686 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -68.97 -34.95 77.78 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.11 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -73.32 -33.01 64.92 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.258 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 7' ' ' LYS . 76.4 t -54.9 -32.25 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.686 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 28.6 tp -51.45 -36.45 44.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.06 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 10' ' ' ALA . 4.1 tttt -77.13 -36.31 55.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.037 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.59 -6.58 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.146 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.115 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.67 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 11.4 pttp . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.461 0.648 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.746 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.09 -107.14 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -176.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 44.9 mtmt -91.5 -10.39 40.97 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 121.956 0.884 . . . . 0.0 112.745 -175.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.63 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -98.31 -25.77 14.73 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.426 177.266 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.67 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 28.4 t80 -61.55 -25.49 67.33 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 176.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -86.16 -26.13 25.32 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 112.695 -2.048 . . . . 0.0 108.652 178.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.746 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -87.51 -16.39 34.82 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.891 178.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.586 ' N ' ' O ' ' A' ' 4' ' ' LEU . 10.5 mt -95.36 -30.01 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.802 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.72 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -74.32 -32.36 58.14 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.965 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.91 -34.54 64.41 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.086 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 7' ' ' LYS . 63.9 t -55.02 -32.03 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.72 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 5.2 tp -50.06 -36.96 31.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.234 176.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 34.7 mmtm -78.53 -36.22 45.11 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.147 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -78.91 -2.76 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.313 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.645 HD13 HG12 ' A' ' 11' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.1 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.668 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.383 0.611 . . . . 0.0 111.587 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.759 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.03 -107.0 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 118.437 2.754 . . . . 0.0 118.437 -176.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.53 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 16.0 tttt -91.8 -9.69 42.62 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.952 0.882 . . . . 0.0 112.804 -175.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.656 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.9 OUTLIER -98.18 -26.99 14.37 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.197 177.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.668 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 32.0 t80 -61.4 -24.97 66.88 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 176.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -85.51 -26.98 25.91 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 112.87 -1.968 . . . . 0.0 108.712 178.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HG2' ' HG ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.22 -15.71 35.22 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.937 178.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.561 ' N ' ' O ' ' A' ' 4' ' ' LEU . 48.5 mt -94.09 -30.92 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.871 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.652 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -68.32 -34.89 81.23 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.234 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -75.41 -31.96 60.59 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.32 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -31.62 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.652 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -54.17 -42.69 69.91 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.264 176.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 10' ' ' ALA . 14.9 ttmt -65.83 -38.48 89.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.4 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.07 -8.65 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.805 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.072 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.689 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.276 0.56 . . . . 0.0 111.551 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.764 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.9 -107.97 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 118.364 2.727 . . . . 0.0 118.364 -176.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.615 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 13.3 mmtt -90.96 -11.3 39.4 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 122.07 0.938 . . . . 0.0 112.36 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.811 HD23 ' HB3' ' A' ' 7' ' ' LYS . 3.5 mt -98.27 -25.61 14.8 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-N 114.198 -1.364 . . . . 0.0 108.797 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.689 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 44.1 t80 -63.17 -23.76 67.58 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.615 ' HG2' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -83.93 -27.75 28.34 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 113.07 -1.877 . . . . 0.0 107.852 177.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.811 ' HB3' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -84.6 -12.73 53.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.205 177.08 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 4' ' ' LEU . 12.2 mt -95.0 -28.92 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.417 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.895 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -72.25 -33.65 61.65 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -74.23 -31.37 62.57 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.466 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 7' ' ' LYS . 96.0 t -56.6 -29.71 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.895 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 62.7 mt -57.04 -31.39 65.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.379 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -79.7 -38.91 32.45 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.505 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.18 -20.69 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.333 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.194 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.696 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 4.1 pttp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.257 0.551 . . . . 0.0 111.925 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.755 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -77.12 -107.37 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 118.48 2.77 . . . . 0.0 118.48 -176.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.545 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -91.01 -10.83 40.8 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 121.931 0.872 . . . . 0.0 112.621 -175.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.659 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -98.49 -25.07 14.89 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.585 177.196 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.696 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 37.1 t80 -61.38 -25.69 67.34 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -84.3 -28.8 26.88 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 112.721 -2.036 . . . . 0.0 108.395 178.104 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.431 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -85.87 -9.37 57.08 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.55 177.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.556 ' N ' ' O ' ' A' ' 4' ' ' LEU . 14.8 mm -94.64 -33.61 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.666 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.687 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -61.37 -39.33 97.11 Favored Glycine 0 C--N 1.314 -0.657 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.599 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -75.83 -28.41 58.26 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.177 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.21 -32.42 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.687 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 61.9 mt -54.11 -42.66 69.67 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.077 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 27.4 mttp -67.79 -34.53 76.96 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.827 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -78.51 -5.85 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.076 -179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.061 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.547 ' CB ' ' HB2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.736 0.303 . . . . 0.0 111.601 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.73 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -75.04 -106.91 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 119.408 3.114 . . . . 0.0 119.408 -175.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 7.5 mtpp -90.19 -10.79 43.11 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.995 0.902 . . . . 0.0 112.866 -174.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.784 HD23 ' HB3' ' A' ' 7' ' ' LYS . 1.0 OUTLIER -98.35 -25.42 14.83 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.464 177.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.547 ' HB2' ' CB ' ' A' ' 1' ' ' LYS . 19.3 t80 -60.41 -26.51 66.75 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.542 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -84.07 -28.2 27.74 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 112.623 -2.08 . . . . 0.0 108.649 178.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.784 ' HB3' HD23 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -84.36 -16.91 41.19 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.548 ' N ' ' O ' ' A' ' 4' ' ' LEU . 24.1 mt -89.63 -33.96 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.617 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.86 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -68.99 -34.9 77.58 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.586 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -69.31 -29.02 66.78 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.946 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 7' ' ' LYS . 61.4 t -54.75 -33.94 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.86 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 2.8 mm? -51.69 -34.89 40.59 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.473 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.586 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 20.4 mttm -76.71 -38.15 54.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.991 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 2.2 t -76.12 -9.64 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.708 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.049 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 5' ' ' PHE . 3.2 ptpp? . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.268 0.556 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.921 ' CH2' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.33 -95.17 0.1 Allowed 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -178.14 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.784 ' N ' ' HE3' ' A' ' 2' ' ' TRP . 0.1 OUTLIER -80.15 4.38 17.58 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 121.643 0.735 . . . . 0.0 111.883 -179.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.921 HD22 ' CH2' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -93.39 -45.9 7.59 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 177.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.599 ' HB2' ' O ' ' A' ' 1' ' ' LYS . 0.2 OUTLIER -51.29 -34.11 31.65 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 111.711 -2.495 . . . . 0.0 108.159 177.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER -80.26 -25.48 39.47 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 112.503 -2.135 . . . . 0.0 109.102 178.06 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 4' ' ' LEU . 12.2 ttpt -89.05 -12.19 41.99 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.374 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' A' ' 4' ' ' LEU . 26.7 mt -89.25 -30.63 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.507 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.742 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -70.43 -35.22 68.58 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -68.63 -30.46 69.18 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.863 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 7' ' ' LYS . 83.7 t -55.56 -32.2 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.742 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 81.0 mt -50.38 -36.26 31.79 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 56.0 mttt -78.83 -36.52 42.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.751 -1.568 . . . . 0.0 110.308 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -78.59 -4.65 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.157 -179.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.135 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.601 ' O ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 121.429 0.633 . . . . 0.0 111.478 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.917 ' CH2' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.78 -95.85 0.1 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -178.032 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.803 ' N ' ' HE3' ' A' ' 2' ' ' TRP . 3.5 mptp? -80.05 4.79 16.01 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-O 121.584 0.707 . . . . 0.0 111.894 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.917 HD22 ' CH2' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -93.07 -48.26 6.58 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.038 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.601 ' HB2' ' O ' ' A' ' 1' ' ' LYS . 0.3 OUTLIER -51.54 -35.55 41.32 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 111.521 -2.581 . . . . 0.0 107.733 177.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.503 ' HG2' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -76.0 -26.44 56.71 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 112.531 -2.122 . . . . 0.0 108.939 177.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.697 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -88.98 -10.61 47.01 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.56 178.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 4' ' ' LEU . 22.8 mt -92.94 -29.27 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.617 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.784 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -73.33 -33.59 58.7 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -72.6 -31.4 65.16 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.142 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 7' ' ' LYS . 81.7 t -55.71 -31.48 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 177.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.784 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 59.5 mt -52.82 -35.45 57.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.358 176.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 3.9 mmpp? -76.72 -39.09 53.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.063 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.406 ' O ' ' CG1' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -76.75 -8.43 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.896 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.136 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.69 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.033 0.444 . . . . 0.0 111.526 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.751 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -78.16 -108.26 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 118.515 2.783 . . . . 0.0 118.515 -176.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 10.1 ttpp -91.9 -10.82 38.19 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 122.077 0.941 . . . . 0.0 112.676 -175.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.678 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 1.4 mp -97.99 -26.65 14.56 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.354 -1.293 . . . . 0.0 108.215 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.69 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 32.9 t80 -61.27 -24.89 66.72 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 176.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -85.62 -27.2 25.6 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 112.778 -2.01 . . . . 0.0 108.84 178.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.716 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -90.76 -13.4 34.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.268 178.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 4' ' ' LEU . 46.1 mt -94.21 -32.61 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.751 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.725 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -73.9 -31.19 60.37 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.149 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.68 -34.93 65.11 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.969 -0.693 . . . . 0.0 110.161 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 7' ' ' LYS . 72.9 t -55.17 -31.23 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.725 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 29.2 tp -50.86 -36.86 39.9 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.123 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.2 mmtp -78.55 -36.29 44.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.154 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -78.46 -3.61 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.323 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.077 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.677 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.125 0.488 . . . . 0.0 112.196 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.749 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.39 -107.18 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 118.531 2.789 . . . . 0.0 118.531 -176.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 4.6 ttpt -91.32 -10.67 40.45 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.921 0.867 . . . . 0.0 112.71 -175.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.629 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 1.3 mp -98.16 -26.37 14.59 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.441 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.677 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 34.7 t80 -61.3 -25.27 67.01 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -85.53 -26.75 26.01 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 112.776 -2.011 . . . . 0.0 108.702 178.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.588 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -86.72 -16.49 36.28 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.677 177.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.553 ' N ' ' O ' ' A' ' 4' ' ' LEU . 72.4 mt -95.39 -31.08 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.956 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.799 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -76.43 -29.06 58.67 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.609 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -77.31 -38.63 50.15 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.736 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 7' ' ' LYS . 89.0 t -55.63 -31.36 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.799 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 2.6 tm? -51.77 -33.61 35.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.348 -1.297 . . . . 0.0 108.739 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -83.75 -35.72 24.17 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.343 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 14' ' ' VAL . 41.1 t -81.37 3.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.276 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.108 -179.518 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.539 ' CB ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.881 0.372 . . . . 0.0 111.732 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.75 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -74.57 -106.6 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 119.165 3.024 . . . . 0.0 119.165 -176.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 9.8 mttt -91.27 -8.89 47.03 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 121.841 0.829 . . . . 0.0 112.844 -175.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.658 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -98.35 -26.17 14.58 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.172 176.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.539 ' HB2' ' CB ' ' A' ' 1' ' ' LYS . 21.2 t80 -60.73 -26.47 67.22 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.54 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -84.46 -27.14 27.71 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 112.634 -2.076 . . . . 0.0 108.686 178.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.656 ' O ' HG23 ' A' ' 11' ' ' VAL . 1.4 pttt -85.69 -17.84 34.84 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.554 ' N ' ' O ' ' A' ' 4' ' ' LEU . 8.1 mt -92.38 -29.57 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.702 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.695 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -72.77 -33.76 60.03 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.947 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -71.61 -31.47 66.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.958 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 7' ' ' LYS . 79.0 t -55.12 -31.88 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.695 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 31.9 tp -52.59 -35.27 53.89 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.623 -1.172 . . . . 0.0 108.351 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -75.93 -40.06 54.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.053 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.04 -9.04 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.882 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.46 HD13 HG12 ' A' ' 11' ' ' VAL . 2.0 tp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.212 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.628 ' O ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.224 0.535 . . . . 0.0 111.662 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.811 ' HE3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -89.22 -94.87 0.1 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -178.169 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.811 ' N ' ' HE3' ' A' ' 2' ' ' TRP . 0.1 OUTLIER -79.9 5.04 14.85 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 121.726 0.774 . . . . 0.0 111.867 -179.444 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.759 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 3.4 mt -94.65 -47.39 6.53 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 177.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.628 ' HB2' ' O ' ' A' ' 1' ' ' LYS . 0.3 OUTLIER -53.87 -34.7 60.17 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 111.614 -2.539 . . . . 0.0 107.889 177.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -77.48 -25.27 50.28 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.753 -2.022 . . . . 0.0 108.38 177.378 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.631 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -88.1 -8.24 55.77 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.212 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' A' ' 4' ' ' LEU . 5.9 mm -93.29 -30.55 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.316 0.579 . . . . 0.0 110.159 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.826 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -73.13 -32.21 60.72 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.041 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.09 -33.76 65.8 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.116 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 7' ' ' LYS . 96.5 t -55.79 -30.75 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.826 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 1.0 OUTLIER -53.85 -33.27 55.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.653 176.523 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 6.9 mtmm -79.33 -39.12 33.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.505 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 20.3 t -69.42 -18.72 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.387 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.344 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.694 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 2.4 pttp . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.46 0.647 . . . . 0.0 111.623 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.747 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.67 -105.95 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 119.052 2.982 . . . . 0.0 119.052 -176.249 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.507 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 8.1 mmtp -89.64 -13.06 37.87 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.856 0.836 . . . . 0.0 112.736 -175.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.611 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -98.16 -27.09 14.34 Favored 'General case' 0 C--N 1.284 -2.283 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.062 177.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.694 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 76.7 t80 -63.14 -22.22 66.72 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -86.81 -27.83 23.3 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 113.111 -1.859 . . . . 0.0 108.051 177.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.831 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -86.05 -7.88 58.31 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.436 177.471 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.501 ' N ' ' O ' ' A' ' 4' ' ' LEU . 65.7 mt -95.39 -33.34 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.041 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.767 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -64.89 -36.45 93.11 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.163 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -75.21 -34.62 61.51 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.231 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 7' ' ' LYS . 84.9 t -55.84 -30.61 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.767 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -52.8 -34.75 54.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.383 176.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 10' ' ' ALA . 5.4 tptp -78.8 -39.53 35.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.05 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 2.6 t -74.49 -9.62 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.783 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 tp . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.235 -179.611 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.591 ' CB ' ' HB2' ' A' ' 5' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 120.846 0.355 . . . . 0.0 111.838 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.713 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -74.22 -107.41 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 119.432 3.123 . . . . 0.0 119.432 -175.718 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.561 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 74.9 mttt -91.01 -9.7 44.97 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 122.025 0.917 . . . . 0.0 112.739 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.679 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.1 OUTLIER -98.95 -24.75 14.82 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.399 176.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.591 ' HB2' ' CB ' ' A' ' 1' ' ' LYS . 41.9 t80 -62.06 -24.81 67.31 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 3' ' ' LYS . 1.0 OUTLIER -84.71 -28.06 26.58 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 112.731 -2.031 . . . . 0.0 108.07 177.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.648 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -84.75 -12.25 54.11 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.386 177.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.566 ' N ' ' O ' ' A' ' 4' ' ' LEU . 43.0 mt -95.81 -32.76 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.227 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.805 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -70.28 -31.76 68.79 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.471 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -77.16 -37.94 52.77 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.633 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 7' ' ' LYS . 91.4 t -55.84 -30.2 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.805 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 14.3 tp -52.08 -37.03 52.62 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.506 -1.224 . . . . 0.0 107.887 176.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 4.1 mtmm -81.22 -31.91 33.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.405 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.568 ' CG1' HG13 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -79.01 7.07 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.715 -178.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.9 tp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.387 -179.142 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.694 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.437 0.637 . . . . 0.0 111.467 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.748 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.5 -107.09 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 118.479 2.77 . . . . 0.0 118.479 -176.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.539 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 14.8 mtpp -90.95 -11.11 40.01 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 122.035 0.922 . . . . 0.0 112.625 -175.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.638 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -98.28 -25.36 14.88 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.679 177.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.694 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 33.2 t80 -61.57 -25.33 67.25 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.539 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -84.81 -27.72 26.61 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 112.86 -1.973 . . . . 0.0 108.477 178.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.628 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -86.21 -14.14 44.81 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.739 177.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' LEU . 40.4 mt -95.73 -31.21 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.739 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.775 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -69.5 -33.2 71.97 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.46 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -76.27 -38.35 56.35 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.477 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 7' ' ' LYS . 96.0 t -55.27 -31.06 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.775 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 48.1 tp -49.84 -37.01 28.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.111 176.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.0 mmpt? -80.89 -34.83 33.28 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.632 -1.622 . . . . 0.0 110.159 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.617 HG12 HG13 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -79.65 0.53 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.376 -179.482 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.12 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.685 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.458 0.647 . . . . 0.0 111.571 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.761 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -77.99 -107.31 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 118.553 2.797 . . . . 0.0 118.553 -176.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.57 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -91.17 -11.2 39.1 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.054 0.93 . . . . 0.0 112.523 -175.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.654 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -98.34 -25.67 14.75 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.606 177.252 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.685 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 27.3 t80 -61.28 -25.26 66.98 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 176.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -83.87 -28.65 27.81 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 112.885 -1.962 . . . . 0.0 108.335 178.203 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.787 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -81.83 -17.09 48.65 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.291 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 4' ' ' LEU . 1.7 mp -99.48 -29.41 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.372 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.836 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -72.96 -33.14 60.03 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.95 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -77.05 -36.82 55.69 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.795 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 7' ' ' LYS . 94.5 t -56.54 -30.29 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.836 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 66.8 tp -52.08 -34.63 44.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.448 176.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 23.9 mtpp -81.73 -38.13 26.22 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.226 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.558 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 7.6 t -75.99 -7.69 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.965 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.732 HD13 HG12 ' A' ' 11' ' ' VAL . 1.4 tp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.12 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.674 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 18.6 pttm . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.523 0.677 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.753 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.03 -107.04 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 118.375 2.731 . . . . 0.0 118.375 -176.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.53 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 0.2 OUTLIER -91.54 -10.27 41.25 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.846 0.832 . . . . 0.0 112.593 -175.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.631 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.1 OUTLIER -98.37 -25.72 14.73 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.442 177.175 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.674 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 25.6 t80 -61.01 -25.94 67.25 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -85.41 -26.84 26.16 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 112.721 -2.036 . . . . 0.0 108.669 178.346 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.807 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -88.05 -14.42 39.01 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.096 178.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.593 ' N ' ' O ' ' A' ' 4' ' ' LEU . 44.8 mt -96.53 -30.41 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.811 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.836 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -74.88 -31.21 58.35 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.16 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 13' ' ' LYS . . . -77.06 -34.41 57.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.388 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 7' ' ' LYS . 86.5 t -55.62 -31.36 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.836 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 68.5 mt -53.27 -35.54 60.18 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.305 176.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 10' ' ' ALA . 65.3 tttt -76.14 -40.14 53.42 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.046 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.04 -9.08 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.817 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.586 HD23 HG12 ' A' ' 11' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.098 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.695 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.142 0.496 . . . . 0.0 111.705 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.766 ' CE3' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -77.86 -107.95 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 118.32 2.711 . . . . 0.0 118.32 -176.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.551 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -91.96 -10.65 38.62 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.094 0.95 . . . . 0.0 112.554 -175.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.692 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 1.5 mp -98.2 -25.96 14.71 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.272 177.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.695 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 28.3 t80 -61.01 -25.69 67.08 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 176.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.551 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -83.85 -28.64 27.86 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 112.75 -2.023 . . . . 0.0 108.695 178.453 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.805 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -86.38 -13.73 45.52 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.736 177.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 4' ' ' LEU . 11.2 mt -94.48 -31.35 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.874 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.828 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -64.64 -37.28 94.18 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.297 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -75.67 -32.76 60.29 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.243 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 7' ' ' LYS . 68.0 t -56.37 -31.16 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.828 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 27.6 mt -52.86 -35.24 57.35 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.403 176.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 9.1 mttp -77.5 -40.16 43.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.14 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.424 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 1.9 t -75.81 -9.65 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.863 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.131 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.672 ' CA ' ' HB2' ' A' ' 5' ' ' PHE . 6.9 pttt . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.46 0.648 . . . . 0.0 111.481 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.759 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -76.28 -107.0 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 -176.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.525 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 0.2 OUTLIER -91.39 -10.06 42.46 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.986 0.898 . . . . 0.0 112.663 -175.736 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.63 ' HB2' ' CZ3' ' A' ' 2' ' ' TRP . 0.1 OUTLIER -98.36 -25.86 14.68 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.452 177.15 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.672 ' HB2' ' CA ' ' A' ' 1' ' ' LYS . 28.3 t80 -61.17 -25.66 67.17 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 2.3 ptmt -85.43 -26.96 26.07 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 112.67 -2.059 . . . . 0.0 108.639 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.711 ' O ' HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -86.88 -16.39 36.16 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.928 177.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.587 ' N ' ' O ' ' A' ' 4' ' ' LEU . 24.9 mt -94.3 -31.05 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.716 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.729 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -72.06 -33.25 62.5 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.95 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -73.22 -33.46 65.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.102 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 7' ' ' LYS . 66.0 t -55.43 -30.23 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.729 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 46.7 tp -53.61 -35.2 60.64 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.404 176.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 7.8 mmtt -77.22 -39.82 47.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.095 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 1.1 t -75.86 -9.3 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.795 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.444 HD13 HG12 ' A' ' 11' ' ' VAL . 2.2 tp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.132 -179.73 . . . . . . . . 1 1 . 1 stop_ save_